Hemos leído sobre ... Vasculitis

Última actualización: 3 junio 2024
MAYO 2024
  • Amorim-Figueiredo R, Pereira Lemos A, Rito T, Conde M, Brito MJ, Pinto F.
    Multiresistant Kawasaki Disease in a Young Infant with Giant Aneurysms Growing Fast.
    J Cardiovasc Dev Dis. 2024 May 14;11(5):149. doi: 10.3390/jcdd11050149.

  • Kassa HL, Singh S, Douglas-Jones M, Schermbrucker G, De Lange J, Phoya F, et al.
    Scurvy masquerading as IgA vasculitis.
    Pediatr Rheumatol Online J. 2024 May 18;22(1):56. doi: 10.1186/s12969-024-00992-2.

  • Nie N, Liu L, Bai C, Wang D, Gao S, Liu J, et al.
    Eosinophilic granulomatous polyangiitis with central nervous system involvement in children: a case report and literature review.
    Front Immunol. 2024 May 15;15:1406424. doi: 10.3389/fimmu.2024.1406424.

  • Abacar K, Kaymaz-Tahra S, Bayındır Ö, İnce B, Kutu ME, Yazıcı A, et al.
    Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study.
    Clin Rheumatol. 2024 May;43(5):1571-1578. doi: 10.1007/s10067-024-06939-y

  • Tanaka R, Tanese K, Ito Y, Takeuchi S, Morimoto A, Sujino K, et al.
    Clinical and laboratory findings characterizing the need for systemic corticosteroids and nonsteroidal systemic therapies, and the predicted outcomes in cutaneous polyarteritis nodosa: A single-centre retrospective analysis.
    Clin Exp Dermatol. 2024 May 9:llae143. doi: 10.1093/ced/llae143. Online ahead of print.

ABRIL 2024
  • Mastrolia MV, Martini M, Memmini G, Ferrara G, Bernardini R, Peroni D, et al.
    Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey.
    Clin Exp Rheumatol. 2024 Apr;42(4):931-936. doi: 10.55563/clinexprheumatol/l64q51. Epub 2024 Apr 29

  • Mastrolia MV, Matucci-Cerinic C, Ozen S, Kasapcopur O, Gaggiano C, Koné-Paut I, et al; EUROFEVER REGISTRY and Pediatric Rheumatology International trial organization (PRINTO).
    Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry.
    Semin Arthritis Rheum. 2024 Jun;66:152454. doi: 10.1016/j.semarthrit.2024.152454. Epub 2024 Apr 23.

  • Hassold N, Dusser P, Laurent A, Lemelle I, Pillet P, Comarmond C, Mekinian A, Lambert M, Mirault T, Benhamou Y, Belot A, Jeziorski E, Reumaux H, Sibilia J, Desdoits A, Espitia O, Faye A, Quartier P, Saadoun D, Koné-Paut I.
    Clinical spectrum and outcome of Takayasu's arteritis in children
    Joint Bone Spine. 2024 Apr 15;91(5):105735. doi: 10.1016/j.jbspin.2024.105735. Online ahead of print.

MARZO 2024
  • Sun Q, Bai J, Wang S, Fang H, Qiao J.
    JAK Inhibitors for Treating Steroid-Dependent IgA Vasculitis.
    Am J Ther. 2024 Mar 20. doi: 10.1097/MJT.0000000000001683. Online ahead of print.

  • Gambichler T, Bui D, Domin B, Ardabili L, Devrim Y, Abu Rached N, Susok L.
    Comparison of clinical and laboratory data of adult patients with cutaneous IgA-vasculitis and non-IgA vasculitis.
    Clin Exp Dermatol. 2024 Mar 6:llae062. doi: 10.1093/ced/llae062. Online ahead of print.

  • Burns JC.
    The etiologies of Kawasaki disease.
    J Clin Invest. 2024 Mar 1;134(5):e176938. doi: 10.1172/JCI176938.

  • Yang P, Zhang J, Feng S, Yi Q.
    A prediction model for differentiating recurrent Kawasaki disease from other febrile illnesses.
    Eur J Intern Med. 2024 Mar 21:S0953-6205(24)00128-6. doi: 10.1016/j.ejim.2024.03.020. Online ahead of print.

  • Kumrah R, Goyal T, Rawat A, Singh S.
    Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.
    Clin Rev Allergy Immunol. 2024 Mar 11. doi: 10.1007/s12016-024-08985-5. Online ahead of print.

  • Lin IC, Suen JL, Huang SK, Chou MH, Kuo HC, Lo MH, Kuo KC, Wang L.
    Involvement of IL-17 A/IL-17 Receptor A with Neutrophil Recruitment and the Severity of Coronary Arteritis in Kawasaki Disease.
    J Clin Immunol. 2024 Mar 7;44(3):77. doi: 10.1007/s10875-024-01673-1.

  • Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group.
    KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
    Kidney Int. 2024 Mar;105(3S):S71-S116. doi: 10.1016/j.kint.2023.10.008.

  • Souza Pedreira AL, Leite de Castro Flores M, Barreto Santiago M.
    Interleukin 6 Levels and Disease Activity in Takayasu Arteritis: A Systematic Review With Meta-analysis.
    J Clin Rheumatol. 2024 Mar 1;30(2):58-64. doi: 10.1097/RHU.0000000000002053.

  • Zhou Z, Fang C, Wang L, Li J, Yang Y, Zhang L, et al.
    Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre.
    RMD Open. 2024 Mar 22;10(1):e003985. doi: 10.1136/rmdopen-2023-003985.

  • Zhong L, Wang W, Tang X, Zhang Y, Gou L, Wang L, et al.
    Phenotype of Takayasu-like vasculitis and cardiopathy in patients with Blau syndrome.
    Clin Rheumatol. 2024 Mar;43(3):1171-1181. doi: 10.1007/s10067-024-06876-w. 

  • Rigante D, Guerriero C, Silvaroli S, Paradiso FV, Sodero G, Laferrera F, Franceschi F, Candelli M.
    Predictors of Gastrointestinal Involvement in Children with IgA Vasculitis: Results from a Single-Center Cohort Observational Study.
    Children (Basel). 2024 Feb 7;11(2):215. doi: 10.3390/children11020215.

  • Cao Y, Chen X, Peng Q, Huang TT, Fan XC.
    Clinical characteristics and risk factors of cardiac involvement in pediatric immunoglobulin A vasculitis: A 7-year retrospective study from a single tertiary medical center.
    Eur J Pediatr. 2024 Feb 1. doi: 10.1007/s00431-024-05438-1.

  • Jia L, Li X, Shen J, Teng Y, Zhang B, Zhang M, Gu Y, Xu H.
    Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous.
    Open Life Sci. 2024 Feb 8;19(1):20220812. doi: 10.1515/biol-2022-0812.

  • Fanous N, Clarke E, Levy ML.
    Posterior reversible encephalopathy syndrome in the setting of IgA vasculitis.
    Pediatr Dermatol. 2024 Feb 18. doi: 10.1111/pde.15569. Epub ahead of print.

  • Kumrah R, Goyal T, Rawat A, Singh S.
    Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.
    Clin Rev Allergy Immunol. 2024 Feb;66(1):99-111. doi: 10.1007/s12016-024-08985-5. Epub 2024 Mar 11. PMID: 38462555.

  • La Vecchia A, Stracquadaino R, Mauri L, Baselli LA, Abdallah R, Cucchetti M, Colli AM, Agostoni C, Dellepiane RM.
    Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.
    BMC Pediatr. 2024 Feb 23;24(1):139. doi: 10.1186/s12887-024-04623-3.

  • Zhang M, Wang C, Li Q, Wang H, Li X.
    Risk factors and an early predictive model for Kawasaki disease shock syndrome in Chinese children.
    Ital J Pediatr. 2024 Feb 3;50(1):22. doi: 10.1186/s13052-024-01597-x.

  • Xu L, Qian GH, Zhu L, Huang HB, Huang CC, Qin J, et al.
    Ubiquitin ligase MDM2 mediates endothelial inflammation in Kawasaki disease vasculitis development.
    Transl Pediatr. 2024 Feb 29;13(2):271-287. doi: 10.21037/tp-23-459.

  • Bahal M, Kumar G, Mane S, Chavan S, Gupta A.
    Early-Onset Takayasu Arteritis in Childhood: A Case Report.
    Cureus. 2024 Feb 8;16(2):e53885. doi: 10.7759/cureus.53885.

  • Renson T, Kelly MM, Benediktsson H, Grundhoefer N, Luca N, Miettunen P, Twilt M, Grisaru S, Wade A, Banks A, Fifi-Mah A, Hamiwka L, Benseler S.
    Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review.
    RMD Open. 2024 Feb 9;10(1):e003579. doi: 10.1136/rmdopen-2023-003579.

  • Hu D, She CH, Bao HF, Zou J, Cai JF, Ye JF, Shen Y, Ma HF, Luo D, Guan JL.
    Clinical heterogeneity and five phenotypes identified in pediatric Behçet's syndrome: a cohort study from Shanghai Behçet's syndrome database.
    World J Pediatr. 2024 Feb 5. doi: 10.1007/s12519-023-00785-9.

ENERO 2024
  • Parums DV.
    A Review of IgA Vasculitis (Henoch-Schonlein Purpura) Past, Present, and Future
    Med Sci Monit. 2024 Jan 28;30:e943912. doi: 10.12659/MSM.943912.

  • Shen M, Liu D, Ye F, Zhang J, Wang J.
    Kawasaki disease in neonates: a case report and literature review.
    Pediatr Rheumatol Online J. 2024 Jan 29;22(1):23. doi: 10.1186/s12969-024-00959-3.

  • Chalkia A, Flossmann O, Jones R, Nair JR, Simpson T, Smith R, Willcocks L, Jayne D.
    Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage.
    Nephrol Dial Transplant. 2024 Jan 24:gfae020. doi: 10.1093/ndt/gfae020. Online ahead of print.

  • Marco DN, Gilabert R, Cid MC, Muxí A, Prieto-González S.
    Hybrid [18F]FDG-PET with CT angiography for diagnosis of Takayasu arteritis.
    Rheumatology (Oxford). 2024 Jan 25:keae051. doi: 10.1093/rheumatology/keae051. Online ahead of print.

  • Wang X, Zhou Z, Li J, Su G, Li X.
    Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet's disease.
    Pediatr Rheumatol Online J. 2024 Jan 19;22(1):19. doi: 10.1186/s12969-023-00932-6.

  • Federici S, Cinicola BL, La Torre F, Castagnoli R, Lougaris V, Giardino G, et al.
    Vasculitis and vasculopathy associated with inborn errors of immunity: an overview.
    Front Pediatr. 2024 Jan 31;11:1258301. doi: 10.3389/fped.2023.1258301.

  • Williams CEC, Lamond M, Marro J, Chetwynd AJ, Oni L.
    A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP).
    Clin Rheumatol. 2023 Dec;42(12):3189-3200. doi: 10.1007/s10067-023-06781-8.

  • Wang W, Zhu L, Li X, Liu Z, Lv H, Qian G.
    Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease.
    Front Microbiol. 2023 Dec 22;14:1313838. doi: 10.3389/fmicb.2023.1313838.

  • Phi DL, Dao TL, To MM, Nguyen TB, Nguyen DC, Gautret P, Hoang VT.
    Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children.
    J Korean Med Sci. 2023 Dec 18;38(49):e410. doi: 10.3346/jkms.2023.38.e410.

  • Kaya Akca U, Batu ED, Jelusic M, Calatroni M, Bakry R, Frkovic M, et al.
    Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children.
    Rheumatology (Oxford). 2023 Dec 22:kead693. doi: 10.1093/rheumatology/kead693. Epub ahead of print.

  • Bloom JL, Pickett-Nairn K, Silveira L, Fuhlbrigge RC, Cuthbertson D, Akuthota P, et al.
    The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA-Associated Vasculitis.
    Arthritis Rheumatol. 2023 Dec;75(12):2216-2227. doi: 10.1002/art.42651.

  • Molina B, Padoan R, Urban ML, Novikov P, Caminati M, Taillé C, et al.
    Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
    Ann Rheum Dis. 2023 Dec;82(12):1587-1593. doi: 10.1136/ard-2023-224756.

  • Akbaba TH, Ekici M, Çolpak Aİ, Brown KL, Karadağ Ö, Balci-Peynircioglu B.
    Behçet's syndrome: recent advances to aid diagnosis.
    Clin Exp Med. 2023 Dec;23(8):4079-4090. doi: 10.1007/s10238-023-01226-7.

  • Suzuki K, Akiyama M, Kondo Y, Saito S, Kikuchi J, Hanaoka H, Kaneko Y.
    Re-emphasising the importance of catheter-based angiography to differentiate polyarteritis nodosa from cutaneous arteritis: Two case reports.
    Mod Rheumatol Case Rep. 2023 Dec 29;8(1):133-136. doi: 10.1093/mrcr/rxad064.

  • Tan LW, Wan JL, Zhu CH, Xu H, Xia ZK, Chen LZ, et al.
    Risk factors for renal outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis: a nationwide retrospective study in China.
    World J Pediatr. 2023 Oct 19. doi: 10.1007/s12519-023-00753-3. Online ahead of print.

  • Demir S, Duzova A, Karagoz T, Oguz B, Aykan HH, Satirer O, et al.
    The risk of cardiovascular comorbidity in children with Behçet's disease.
    Rheumatology (Oxford). 2023 Oct 3:kead505. doi: 10.1093/rheumatology/kead505. Online ahead of print.

  • Reicy R, Jari M.
    Comparison of Different Treatment Regimens for Long-term Improvement of Renal Function in Patients with Henoch-Schönlein Purpura: A Systematic Review.
    Curr Rheumatol Rev. 2023 Sep 11. doi: 10.2174/1573397119666230825163008. Online ahead of print.

  • Wang L, Zeng X, Chen B.
    Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease.
    Medicine (Baltimore). 2023 Sep 15;102(37):e34939. doi: 10.1097/MD.0000000000034939.

  • Lee J, Kim BJ, Cho KS, Rhim JW, Lee SY, Jeong DC.
    Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome.
    Children (Basel). 2023 Sep 8;10(9):1527. doi: 10.3390/children10091527.

  • Yadav S, Samant R, Patankar A, Sankhla C.
    Clinical Features and Imaging Characteristics of Intracranial Vascular Involvement in Takayasu Arteritis: An Analysis of 9 Cases.
    J Clin Rheumatol. 2023 Sep 19. doi: 10.1097/RHU.0000000000002024. Online ahead of print.

  • Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, et al.
    Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
    Ann Rheum Dis. 2023 Sep 21:ard-2023-224343. doi: 10.1136/ard-2023-224343. Online ahead of print.

  • Floyd L, Morris AD, Shetty A, Brady ME, Ponnusamy A, Warwicker P, Dhaygude A.
    Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis.
    Kidney360. 2023 Sep 1;4(9):e1286-e1292. doi: 10.34067/KID.0000000000000222.

  • Ishikawa Y, Tokutsu K, Nakayamada S, Kuchiba A, Fushimi K, Matsuda S, Tanaka Y.
    Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database.
    Ann Rheum Dis. 2023 Sep 19:ard-2023-224472. doi: 10.1136/ard-2023-224472. Online ahead of print.

  • Rathmann J, Segelmark M, Mohammad AJ.
    Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden.
    Rheumatology (Oxford). 2023 Sep 27:kead516. doi: 10.1093/rheumatology/kead516. Online ahead of print.

  • Rohmer J, Nguyen Y, Trefond L, Agard C, Allain JS, Berezne A, et al.
    Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients.
    J Autoimmun. 2023 Sep;139:103093. doi: 10.1016/j.jaut.2023.103093. 

  • Marro J, Williams C, Pain CE, Oni L.
    A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children.
    Pediatr Rheumatol Online J. 2023 Aug 14;21(1):85. doi: 10.1186/s12969-023-00872-1.

  • Zhang S, Wang Q, Li Z, Guo Q.
    Testicular ischemia associated with IgA vasculitis in a child: a case report and literature review.
    Front Pediatr. 2023 Aug 11;11:1219878. doi: 10.3389/fped.2023.1219878.

  • Li Y, Zhang X, Liu H, Li G, Guan W, Zhang T, Zeng Q, Gong Y, Xu H, Sun L.
    Severe gastrointestinal involvement in pediatric IgA vasculitis: a retrospective single-center cohort study in China.
    Front Pediatr. 2023 Aug 8;11:1194214. doi: 10.3389/fped.2023.1194214.

  • Lv Y, Fu R, Peng XJ, Wang Y, Yin TT, Deng YQ.
    Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children.
    BMC Pediatr. 2023 Aug 24;23(1):423. doi: 10.1186/s12887-023-04243-3.

  • Tanaka H, Tanaka T, Tokuda O, Yamamoto H, Matsunoshita N, Takenaka K, Tominaga K, Kawasaki K.
    Association between Factor XIII Activity and Clinical Course in Pediatric Patients with Immunoglobulin A Vasculitis.
    Kobe J Med Sci. 2023 Aug 21;69(2):E57-E63.

  • Yang K, Tang J, Li H, Zhang H, Ding J, Li Z, Luo J.
    LncRNAs in Kawasaki disease and Henoch-Schönlein purpura: mechanisms and clinical applications.
    Mol Cell Biochem. 2023 Aug 28. doi: 10.1007/s11010-023-04832-x. Epub ahead of print.

  • Zhang X, Sun Y, Meng L, Ye C, Han H, Zhang T, Feng Y, Li J, Duan L, Chen Y.
    Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility.
    Pediatr Rheumatol Online J. 2023 Aug 7;21(1):78. doi: 10.1186/s12969-023-00857-0.

  • Philip S, Jindal A, Krishna Kumar R.
    An update on understanding the pathophysiology in Kawasaki disease: Possible role of immune complexes in coronary artery lesion revisited.
    Int J Rheum Dis. 2023 Aug;26(8):1453-1463. doi: 10.1111/1756-185X.14816. Epub 2023 Jul 11.

  • R JP, Muddana VRS, Munugala HK, Shriram Dhanasekaran K. Cardiac CT
    Angiography-Guided Management of Giant Coronary Artery Aneurysms in Atypical Kawasaki Disease: A Case Report and Review of Literature.
    Cureus. 2023 Aug 31;15(8):e44425. doi: 10.7759/cureus.44425.

  • Brodeur KE, Liu M, Ibanez D, de Groot MJ, Chen L, Du Y, et al.
    Elevation of IL-17 cytokines distinguishes Kawasaki disease from other pediatric inflammatory disorders
    Arthritis Rheumatol. 2023 Aug 23. doi: 10.1002/art.42680. Online ahead of print.

  • Souni G, Ayad G, Elouali A, Rkain M, Babakhouya A.
    Severe Kawasaki Disease and Thrombocytopenia: A Case Report.
    Cureus. 2023 Aug 3;15(8):e42916. doi: 10.7759/cureus.42916.

  • Kim J, Shimizu C, He M, Wang H, Hoffman HM, Tremoulet AH, Shyy JY, Burns JC.
    Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children.
    Int J Mol Sci. 2023 Aug 1;24(15):12318. doi: 10.3390/ijms241512318.

  • Zhang P, Yao J, Gao CL, Fang X, Zhang ZQ, Xia ZK.
    Validation of a renal risk score in a cohort of children with ANCA-associated glomerulonephritis.
    J Investig Med. 2023 Aug 24:10815589231186534. doi: 10.1177/10815589231186534. Epub ahead of print.

  • Azin N, Hajihashemi A, Geravandi M.
    Rare central nervous system manifestation of granulomatosis with polyangiitis in a 12-year-old child: A case report.
     Radiol Case Rep. 2023 Aug 10;18(10):3704-3709. doi: 10.1016/j.radcr.2023.07.077.

  • Knopp BW, Baran J, Casey R.
    Childhood-Onset Granulomatosis With Polyangiitis as a Palatal Defect: A Case Report.
    Cureus. 2023 Aug 2;15(8):e42855. doi: 10.7759/cureus.42855.

  • Ariyoshi T, Hoshide M, Motonaga T, Korenaga Y, Azuma Y, Ichimura T, Matsushige T, Hasegawa S.
    Childhood primary angiitis of the central nervous system following COVID-19 vaccination (BNT162b2/Pfizer-BioNtech): A case report.
    Hum Vaccin Immunother. 2023 Aug;19(2):2261167. doi: 10.1080/21645515.2023.2261167. Epub 2023 Sep 29.

JULIO 2023
  • Scott C, Stander R, Phoya F.
    Medium-vessel and large-vessel vasculitis in children.
    Curr Opin Rheumatol. 2023 Sep 1;35(5):278-284. doi: 10.1097/BOR.0000000000000955. Epub 2023 Jul 10.

  • Mohankumar SP, Das S, Likitha P, Naranje P, Jana M, Gupta SK, Bagri NK.
    Kawasaki disease or polyarteritis nodosa: coronary involvement, a diagnostic conundrum.
    Rheumatol Int. 2023 Jul 11. doi: 10.1007/s00296-023-05388-1. Epub ahead of print.

  • Singh D, Sukumaran S.
    Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
    Pediatr Rheumatol Online J. 2023 Jul 3;21(1):66. doi: 10.1186/s12969-023-00853-4.

  • Philip S, Jindal A, Krishna Kumar R.
    An update on understanding the pathophysiology in Kawasaki disease: Possible role of immune complexes in coronary artery lesion revisited.
    Int J Rheum Dis. 2023 Aug;26(8):1453-1463. doi: 10.1111/1756-185X.14816. Epub 2023 Jul 11.

MAYO 2023
  • Mary AL, Clave S, Rousset-Rouviere C, Berard E, Boyer O, Decramer S, et al.
    Outcome of children with IgA vasculitis with nephritis treated with steroids: a matched controlled study.
    Pediatr Nephrol. 2023 May 8. doi: 10.1007/s00467-023-05981-3. Online ahead of print.

  • Reddy Konda VV, Jindal AK, Nadig PL, Banday AZ, Vinay K, Singh S.
    Microvascular changes on nailfold capillaroscopy in acute stage of Kawasaki disease-a new diagnostic paradigm for an enigmatic condition.
    Rheumatology (Oxford). 2023 May 18:kead213. doi: 10.1093/rheumatology/kead213. Epub ahead of print.

  • Mori M, Matsubara T.
    Overview of Guidelines for the Medical Treatment of Acute Kawasaki Disease in Japan (2020 Revised Version) and Positioning of Plasma Exchange Therapy in the Acute Phase.
    Pediatr Infect Dis J. 2023 May 18. doi: 10.1097/INF.0000000000003974. Epub ahead of print.

  • Cannon L, Campbell MJ, Wu EY.
    Multisystemic Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment.
    Curr Allergy Asthma Rep. 2023 May 12:1–10. doi: 10.1007/s11882-023-01083-0. Epub ahead of print.

  • Machet T, Quéméneur T, Ledoult E, Mesbah R, Lebas C, Hachulla E, Pokeerbux MR.
    Rituximab resistance at 3 months of induction therapy in newly diagnosed or relapsing ANCA associated vasculitis: a French multicentre study.
    Joint Bone Spine. 2023 May 23:105591. doi: 10.1016/j.jbspin.2023.105591. Online ahead of print.

  • Moura MC, Gauckler P, Anders HJ, Bruchfeld A, Fernandez-Juarez GM, Floege J, et al; ERA Immunonephrology Working Group (IWG).
    Management of anti-neutrophil cytoplasmic antibody associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 Guidelines/Recommendations.
    Nephrol Dial Transplant. 2023 May 10:gfad090. doi: 10.1093/ndt/gfad090. Online ahead of print.

  • Perray L, Nguyen Y, Clavel Refregiers G, Chazal T, Héron E, Pouchelon C, et al.
    ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome.
    Rheumatology (Oxford). 2023 May 26:kead252. doi: 10.1093/rheumatology/kead252. Online ahead of print.

  • Fijolek J, Radzikowska E.
    Eosinophilic granulomatosis with polyangiitis - Advances in pathogenesis, diagnosis, and treatment.
    Front Med (Lausanne). 2023 May 3;10:1145257. doi: 10.3389/fmed.2023.1145257.

ABRIL 2023
  • Alkanhal A, Saunders J, Altammar F, Huber AM, Lynk A, MacLeod A, Ortiz-Alvarez O, Adams M, Ramsey S, Stringer E, Warren A, Lang B.
    Unexpectedly high incidence of Kawasaki Disease in a Canadian Atlantic Province- an 11-year retrospective descriptive study.
    Pediatr Rheumatol Online J. 2023 Apr 3;21(1):30. doi: 10.1186/s12969-023-00805-y.

  • Moretti M, Treppo E, Monti S, La Rocca G, Del Frate G, Delvino P, Italiano N, Di Cianni F, D'Alessandro F, Talarico R, Ferro F, Quartuccio L, Baldini C.
    Systemic vasculitis: one year in review 2023.
    Clin Exp Rheumatol. 2023 Apr;41(4):765-773. doi: 10.55563/clinexprheumatol/zf4daj. Epub 2023 Apr 18.

  • Marvisi C, Ricordi C, Galli E, Muratore F, Boiardi L, Macchioni PL, Pipitone N, Macaluso F, Salvarani C, Brandolino F.
    Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis.
    Clin Exp Rheumatol. 2023 Apr;41(4):975-981. doi: 10.55563/clinexprheumatol/cj4ea8. Epub 2023 Apr 11.

MARZO 2023
  • Hu JJ, Zhao YW, Wen R, Luo YY, Zhou WG, Liu YH, Qin F, Liu C, He TQ.
    IgA vasculitis with testicular/epididymal involvement in children: A retrospective study of a ten-year period.
    Front Pediatr. 2023 Mar 20;11:1141118. doi: 10.3389/fped.2023.1141118.

  • Sestan M, Jelusic M.
    Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch-Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives.
    Pediatric Health Med Ther. 2023 Mar 7;14:89-98. doi: 10.2147/PHMT.S379862. 

  • Wongbundit C, Vijarnsorn C, Pornprasertchai V, Somkittitham P, Bositthipichet D, Tongbunnum T, Chanthong P.
    Coronary changes and cardiac events in children diagnosed with Kawasaki disease without initial coronary aneurysm: A multicenter retrospective cohort study.
    Front Pediatr. 2023 Mar 15;11:1121905. doi: 10.3389/fped.2023.1121905.

  • Wang S, Huang H, Hou M, Xu Q, Qian W, Tang Y, et al.
    Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.
    Pediatr Res. 2023 Mar 24. doi: 10.1038/s41390-023-02558-6. Online ahead of print.

  • Smith RM, Jones RB, Specks U, Bond S, Nodale M, Al-Jayyousi R, et al; RITAZAREM co-investigators.
    Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
    Ann Rheum Dis. 2023 Mar 23:ard-2022-223559. doi: 10.1136/ard-2022-223559. Online ahead of print.

  • Alihosseini C, Kopelman H, Zaino M, Feldman SR.
    Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
    Ann Pharmacother. 2023 Mar 28:10600280231161592. doi: 10.1177/10600280231161592. Online ahead of print.

  • Omura S, Kida T, Noma H, Sunaga A, Kusuoka H, Kadoya M, et al.
    Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.
    Rheumatology (Oxford). 2023 Mar 24:kead138. doi: 10.1093/rheumatology/kead138. Online ahead of print.

  • Benichou N, Charles P, Terrier B, Jones RB, Hiemstra T, Mouthon L, et al; French Vasculitis Study Group (FVSG) and European Vasculitis Society (EUVAS) investigators.
    Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis.
    Kidney Int. 2023 Mar 20:S0085-2538(23)00168-0. doi: 10.1016/j.kint.2023.02.029. Online ahead of print.

  • Tian X, Li M, Jiang N, Zhao Y, Li J, Zhou Y, Wang Y, et al.
    Comparative Efficacy of Secukinumab versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu's Arteritis.
    Arthritis Rheumatol. 2023 Mar 14. doi: 10.1002/art.42496. Online ahead of print.

  • Ucar AK, Ozdede A, Kayadibi Y, Adaletli I, Melikoglu M, Fresko I, Seyahi E.
    Increased arterial stiffness and accelerated atherosclerosis in Takayasu arteritis.
    Semin Arthritis Rheum. 2023 Mar 29;60:152199. doi: 10.1016/j.semarthrit.2023.152199. Online ahead of print.

  • Guo Y, Du J, Li T, Gao N, Yang S, Zhang Y, Pan L.
    Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with Takayasu arteritis.
    Arthritis Res Ther. 2023 Mar 7;25(1):36. doi: 10.1186/s13075-023-03016-8.

  • Gaggiano C, Maselli A, Sfikakis PP, Laskari K, Ragab G, Hegazy MT, et al; AIDA Network.
    Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry.
    Intern Emerg Med. 2023 Mar 7. doi: 10.1007/s11739-023-03215-w. Online ahead of print.

  • Turgeon D, Bakowsky V, Baldwin C, Cabral DA, Clements-Baker M, Clifford A, et al.
    CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum
    Rheumatology (Oxford). 2023 Feb 21:kead087. doi: 10.1093/rheumatology/kead087. Online ahead of print.

  • Datyner E, Adeseye V, Porter K, Dryden I, Sarma A, Vu N, Patrick AE, Paueksakon P.
    Small vessel childhood primary angiitis of the central nervous system with positive anti-glial fibrillary acidic protein antibodies: a case report and review of literatura.
    BMC Neurol. 2023 Feb 3;23(1):57. doi: 10.1186/s12883-023-03093-x.

  • Trindade TS, Morais CG, Maia A, Rodrigues M, Brito I.
    Demographic and clinical features of pediatric vasculitis: a single-center study.
    ARP Rheumatol. 2023 Feb 2. Online ahead of print.

  • Hahn D, Hodson EM, Craig JC.
    Interventions for preventing and treating kidney disease in IgA vasculitis.
    Cochrane Database Syst Rev. 2023 Feb 28;2(2):CD005128. doi: 10.1002/14651858.CD005128.pub4.

  • Pan Y, Fan Q.
    A nomogram for predicting immunoglobulin-resistant Kawasaki disease in children
    J Int Med Res. 2023 Feb;51(2):3000605221139704. doi: 10.1177/03000605221139704.

  • Kato T, Miura M, Kobayashi T, Kaneko T, Fukushima N, Suda K, et al; Z‐Score Project 2nd Stage Study Group.
    Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression.
    J Am Heart Assoc. 2023 Feb 7;12(3):e022417. doi: 10.1161/JAHA.121.022417.

  • Gong X, Tang L, Wu M, Shao S, Zhou K, Hua Y, Wang C, Li Y.
    Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease.
    BMC Pediatr. 2023 Feb 16;23(1):79. doi: 10.1186/s12887-023-03876-8.

  • Li M, Liu D, Jing F, Liu R, Yi Q.
    The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease
    Front Pediatr. 2023 Feb 14;11:1111788. doi: 10.3389/fped.2023.1111788.

  • Guo X, Liao J, Fan X, Xu M.
    Exploring the diagnostic value of eosinophil-to-lymphocyte ratio to differentiate Kawasaki disease from other febrile diseases based on clinical prediction model.
    Sci Rep. 2023 Feb 28;13(1):3399. doi: 10.1038/s41598-023-30463-9.

  • Bronz G, Gianini J, Passi AG, Rizzi M, Bergmann MM, Milani GP, et al
    Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review.
    Autoimmun. 2023 Feb 22;136:103002. doi: 10.1016/j.jaut.2023.103002. Online ahead of print.

  • van der Houwen TB, Humer B, Missotten TO, Thiadens AAHJ, van Hagen PM, van Laar JAM.
    Long-term data on efficacy and safety of adalimumab in Behçet's disease
    Clin Immunol. 2023 Feb;247:109242. doi: 10.1016/j.clim.2023.109242.

ENERO 2023
  • Mahi SL, Bahram S, Harambat J, Allard L, Merlin E, Belot A, et al.
    Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study.
    Pediatr Nephrol. 2023 Jan 9. doi: 10.1007/s00467-022-05855-0. Epub ahead of print.

  • Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T.
    Intravenous immunoglobulin for the treatment of Kawasaki disease.
    Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
  • Odingo M, Rutter M, Bowley J, Peach EJ, Lanyon PC, Grainge MJ, Stillwell P, McPhail S, Bythell M, Aston J, Stevens S, McCormack R, Brogan P, Pearce FA.
    The incidence of Kawasaki disease using hospital admissions data for England 2006-2021.
    Rheumatology (Oxford). 2023 Jan 30:kead051. doi: 10.1093/rheumatology/kead051. Epub ahead of print.
  • Sapountzi E, Fidani L, Giannopoulos A, Galli-Tsinopoulou A.
    Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
    Pediatr Cardiol. 2023 Jan;44(1):1-12. doi: 10.1007/s00246-022-02973-2. Epub 2022 Jul 30.

  • Koyama Y, Miura M, Kobayashi T, Hokosaki T, Suganuma E, Numano F, Furuno K, Shiono J, Ebata R, Fuse S, Fukazawa R, Mitani Y.
    A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Eur J Pediatr. 2023 Feb;182(2):633-640. doi: 10.1007/s00431-022-04719-x. Epub 2022 Nov 25.
  • Shimizu M, Irabu H, Shimbo A, Kaneko S, Mori M.
    Monthly intravenous immunoglobulin for refractory intestinal IgA vasculitis.
    Pediatr Int. 2023 Jan 16:e15470. doi: 10.1111/ped.15470. Online ahead of print.

  • Nassarmadji K, Vanjak A, Bourdin V, Champion K, Burlacu R, Mouly S, Sène D, Comarmond C.
    18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice.
    Front Med (Lausanne). 2023 Jan 19;10:1103752. doi: 10.3389/fmed.2023.1103752

  • Liao LC, Fu YH, Chuang CM, Liao PL, Wei JC, Fu YC.
    Impact of Kawasaki disease on juvenile idiopathic arthritis in real-world patients: A population-based cohort study
    Front Immunol. 2022 Dec 8;13:1025553. doi: 10.3389/fimmu.2022.1025553. eCollection 2022.

  • Cai WJ, Ding SG.
    Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease
    Medicine (Baltimore). 2022 Dec 30;101(52):e32430. doi: 10.1097/MD.0000000000032430.

  • Lu Y, Tang Y, Wang B, Li X, Xu Q, Chu H, Lv H, Lu M, Qin Y.
    Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio
    Ital J Pediatr. 2022 Dec 30;48(1):208. doi: 10.1186/s13052-022-01400-9.

  • Zhu Y, Zheng X.
    Microscopic polyangiitis presenting with persistent cough and hemoptysis in pediatrics: A case report and review of the literature
    Front Oncol. 2022 Dec 6;12:987507. doi: 10.3389/fonc.2022.987507. eCollection 2022.

  • Suhaini SA, Azidin AH, Cheah CS, Lee Wei Li W, Khoo MS, Ismail NAS, Ali A.
    Kawasaki Disease with Hepatobiliary Manifestations
    Medicina (Kaunas). 2022 Dec 12;58(12):1833. doi: 10.3390/medicina58121833.

  • Gibson KM, Drögemöller BI, Foell D, Benseler SM, Graham J, Hancock REW, Luqmani RA, Cabral DA, Brown KL, Ross CJ; PedVas Investigator's Network.
    HLA-DPB1 is associated with ANCA-associated vasculitis in children
    Arthritis Rheumatol. 2022 Dec 18. doi: 10.1002/art.42423. Online ahead of print.

  • Miller-Barmak A, Sztajnbok F, Balik Z, Borzutzky A, Fogel LA, Goldzweig O, Ozen S, Butbul Aviel Y.
     Infantile Takayasu: clinical features and long-term outcome
    Rheumatology (Oxford). 2022 Dec 10:keac691. doi: 10.1093/rheumatology/keac691. Online ahead of print.

  • Zhang X, Che R, Xu H, Ding G, Zhao F, Huang S, Zhang A.
    Hemoperfusion and intravenous immunoglobulins for refractory gastrointestinal involvement in pediatric Henoch-Schönlein purpura: a single-center retrospective cohort study
    BMC Pediatr. 2022 Dec 2;22(1):692. doi: 10.1186/s12887-022-03709-0.

  • Batu ED, Sener S, Ozomay Baykal G, Arslanoglu Aydin E, Özdel S, Gagro A, Esen E, Heshin-Bekenstein M, Akpınar Tekgöz N, Demirkan FG, Ozturk K, Vougiouka O, Sonmez HE, Maggio MC, Kaya Akca U, Jelusic M, Pac Kısaarslan A, Acar B, Aktay Ayaz N, Sözeri B, Özen S.
    The characteristics of patients with COVID-19-associated pediatric vasculitis: an international, multicenter study
    Arthritis Rheumatol. 2022 Dec 1. doi: 10.1002/art.42411. Online ahead of print.

  • Ramdani Y, Largeau B, Jonville-Bera AP, Maillot F, Audemard-Verger A, Ramdani Y, Largeau B, Jonville-Bera AP, Maillot F, Audemard-Verger A.
    COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance Study.
    J Rheumatol. 2022 Nov 15:jrheum.220629. doi: 10.3899/jrheum.220629. Online ahead of print.

  • Marro J, Chetwynd AJ, Edwards S, Wright RD, Oni L.
    Increased Urinary IgA in Paediatric IgA Vasculitis Nephritis.
    Int J Mol Sci. 2022 Nov 22;23(23):14548. doi: 10.3390/ijms232314548.

  • Nishino T, Takahashi K, Tomori S, Ono S, Mimaki M.
    Association of HLA with IgA vasculitis with nephritis in Japanese children.
    Pediatr Int. 2022 Nov 22:e15422. doi: 10.1111/ped.15422. Online ahead of print.
  • Koyama Y, Miura M, Kobayashi T, Hokosaki T, Suganuma E, Numano F, Furuno K, Shiono J, Ebata R, Fuse S, Fukazawa R, Mitani Y.
    A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Eur J Pediatr. 2022 Nov 25. doi: 10.1007/s00431-022-04719-x. Online ahead of print.

  • Robinson C, Chanchlani R, Gayowsky A, Brar S, Darling E, Demers C, Mondal T, Parekh R, Seow H, Batthish M.
    Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study.
    Pediatr Res. 2022 Nov 15. doi: 10.1038/s41390-022-02391-3. Online ahead of print.

  • Sobh A, Mosa DM, Khaled N, Korkor MS, Noureldin MA, Eita AM, Elnagdy MH, El-Bayoumi MA.
    How multisystem inflammatory syndrome in children discriminated from Kawasaki disease: a differentiating score based on an inception cohort study.
    Clin Rheumatol. 2022 Nov 21:1-11. doi: 10.1007/s10067-022-06444-0. Online ahead of print.

  • Fridman MD, Tsoukas P, Jeewa A, Yeung RSM, Gamulka BD, McCrindle BW.
    Differentiation of Multi-system Inflammatory Syndrome Associated with COVID-19 Versus Kawasaki Disease Using Cardiac Biomarkers.
    Can J Cardiol. 2022 Nov 30:S0828-282X(22)01049-2. doi: 10.1016/j.cjca.2022.11.012. Online ahead of print.

  • Yuqing M, Shang G, Qing G, Jiyang W, Ruihao L, Zuoguan C, Yongpeng D, Zhiyuan W, Yongjun L.
    Transcriptome profiling of abdominal aortic tissues reveals alterations in mRNAs of Takayasu arteritis.
    Front Genet. 2022 Nov 16;13:1036233. doi: 10.3389/fgene.2022.1036233. 

  • Liang I, Hamid M, Sebaratnam D, Manolios N.
    The spectrum of cutaneous polyarteritis nodosa. A case report of two contrasting cases and review of the literature.
    Clin Case Rep. 2022 Nov 27;10(11):e6659. doi: 10.1002/ccr3.6659. 

  • Puéchal X, Iudici M, Perrodeau E, Bonnotte B, Lifermann F, Le Gallou T, Karras A, Blanchard-Delaunay C, Quéméneur T, Aouba A, Aumaître O, Cottin V, Hamidou M, Ruivard M, Cohen P, Mouthon L, Guillevin L, Ravaud P, Porcher R, Terrier B; French Vasculitis Study Group.
    Rituximab vs Cyclophosphamide Induction Therapy for Patients with Granulomatosis With Polyangiitis.
    JAMA Netw Open. 2022 Nov 1;5(11):e2243799. doi: 10.1001/jamanetworkopen.2022.43799.

  • Junek ML, Zhao L, Garner S, Cuthbertson D, Pagnoux C, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Rhee RL, Seo P, Specks U, Sreih AG, Warrington K, Wechsler ME, Merkel PA, Khalidi NA; Vasculitis Clinical Research Consortium.
    Ocular manifestations of ANCA-associated vasculitis.
    Rheumatology (Oxford). 2022 Nov 28:keac663. doi: 10.1093/rheumatology/keac663. Online ahead of print.

  • Tabakovic D, Smith R, Jayne D, Mohammad AJ.
    High risk of stroke in ANCA-associated vasculitis-a population-based study.
    Rheumatology (Oxford). 2022 Nov 28:keac669. doi: 10.1093/rheumatology/keac669. Online ahead of print.

  • Takeuchi H, Kawamura K, Kawasaki T, Oka N.
    Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis.
    Front Neurol. 2022 Nov 15;13:1057767. doi: 10.3389/fneur.2022.1057767. 

  • Xu L, Li Y, Wu X.
    IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.
    Front Immunol. 2022 Oct 3;13:921864. doi: 10.3389/fimmu.2022.921864.

  • Wang K, Sun X, Jing S, Lin L, Cao Y, Peng X, Qiao L, Dong L.
    Development and validation of nomogram prediction model for severe kidney disease in children with Henoch-Schönlein purpura: A prospective analysis of two independent cohorts-forecast severe kidney disease outcome in 2,480 hospitalized Henoch-Schönlein purpura children.
    Front Immunol. 2022 Oct 12;13:999491. doi: 10.3389/fimmu.2022.999491. eCollection 2022.

  • Ouldali N, Dellepiane RM, Torreggiani S, Mauri L, Beaujour G, Beyler C, Cucchetti M, Dumaine C, La Vecchia A, Melki I, Stracquadaino R, Vinit C, Cimaz R, Meinzer U.
    Development of a score for early identification of children with Kawasaki disease requiring second-line treatment in multi-ethnic populations in Europe: A multicentre retrospective cohort study.
    Lancet Reg Health Eur. 2022 Aug 6;22:100481. doi: 10.1016/j.lanepe.2022.100481

  • Harrison M, Scalici P.
    Clinical guideline highlights for the hospitalist: Management of Kawasaki disease
    J Hosp Med. 2022 Aug 8. doi: 10.1002/jhm.12935. 

  • Bai B, Ya JL, Yan C.
    Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease
    J Coll Physicians Surg Pak. 2022 Aug;32(8):1037-1041. doi: 10.29271/jcpsp.2022.08.1037.

  • Joung J, Oh JS, Yoon JM, Ko KO, Yoo GH, Cheon EJ.
    A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease
    BMC Pediatr. 2022 Aug 5;22(1):474. doi: 10.1186/s12887-022-03533-6.

  • Yao M, He Q, Yang M, Wu Z, Li Y, Kong M, Kang Z, Yi L, Hu Y, Huang L, Li Z, Yang Z.
    Association of miR-181c/d gene locus rs8108402 C/T polymorphism with susceptibility to Kawasaki disease in Chinese children
    Front Pediatr. 2022 Aug 9;10:899779. doi: 10.3389/fped.2022.899779.

  • Misra DP, Rathore U, Kopp CR, Patro P, Agarwal V, Sharma A.
    Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis
    Clin Rheumatol. 2022 Aug 5. doi: 10.1007/s10067-022-06318-5. 

  • Kang M, Lai J, Zhang D, Xu Y, Zhu J, Li M.
    Clinical observations on infliximab treatment of infantile onset Takayasu arteritis
    Pediatr Rheumatol Online J. 2022 Aug 4;20(1):61. doi: 10.1186/s12969-022-00708-4.
    https://pubmed.ncbi.nlm.nih.gov/ /

  • Fu R, Yang M, Li Z, Kang Z, Xun M, Wang Y, Wang M, Wang X.
    Risk assessment and prediction model of renal damage in childhood immunoglobulin A vasculitis
    Front Pediatr. 2022 Aug 17;10:967249. doi: 10.3389/fped.2022.967249.

  • Yoshida M, Nambu R, Yasuda R, Sakaguchi H, Hara T, Iwama I, Mizuochi T.
    Dapsone for Refractory Gastrointestinal Symptoms in Children With Immunoglobulin A Vasculitis
    Pediatrics. 2022 Aug 17:e2021055884. doi: 10.1542/peds.2021-055884. 

JULIO 2022
  • Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    J Pediatr. 2022 Jan;240:158-163.e4. doi: 10.1016/j.jpeds.2021.08.065.

  • Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Clin Exp Med. 2022 Jan 18. doi: 10.1007/s10238-021-00776-y. Epub ahead of print.

  • Hoshino S, Shibata Y, Matsubayashi J, Ae R.
    Regional Differences in Kawasaki Disease Incidence Reduction Before and After the Onset of the Coronavirus Disease 2019 Pandemic.
    J Pediatr. 2022 Jul 16:S0022-3476(22)00627-8. doi: 10.1016/j.jpeds.2022.07.008. Epub ahead of print.

  • Wu D, Ma R, Wang X, Yang Y.
    Efficacy and Safety of Tacrolimus in the Treatment of Pediatric Henoch-Schönlein Purpura Nephritis.
    Paediatr Drugs. 2022 Jul;24(4):389-401. doi: 10.1007/s40272-022-00506-1.

  • Zucker EJ, Chan FP.
    Pediatric cardiothoracic vasculitis: multimodality imaging review.
    Pediatr Radiol. 2022 Jul 6:1–15. doi: 10.1007/s00247-022-05431-6. Epub ahead of print.

  • Al-Soudi A, Vegting Y, Klarenbeek PL, Hilhorst ML.
    Do Relapses Follow ANCA Rises? A Systematic Review and Meta-Analysis on the Value of Serial ANCA Level Evaluation.
    Front Med (Lausanne). 2022 Jul 4;9:844112. doi: 10.3389/fmed.2022.844112.

MAYO 2022
  • Green J, Wardle AJ, Tulloh RM.
    Corticosteroids for the treatment of Kawasaki disease in children.
    Cochrane Database Syst Rev. 2022 May 27;5(5):CD011188. doi: 10.1002/14651858.CD011188.pub3.

  • Srivastava P, Bamba C, Pilania RK, Kumari A, Kumrah R, Sil A, Singh S.
    Exploration of Potential Biomarker Genes and Pathways in Kawasaki Disease: An Integrated in-Silico Approach.
    Front Genet. 2022 May 9;13:849834. doi: 10.3389/fgene.2022.849834. 

  • Bossi G, Codazzi AC, Vinci F, Clerici E, Regalbuto C, Crapanzano C, Veraldi D, Moiraghi A, Marseglia GL.
    Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome.
    Children (Basel). 2022 May 5;9(5):672. doi: 10.3390/children9050672.

  • Carmona-Cruz SA, Durán-McKinster LC, García-Romero MT.
    Atypical purpura and other features associated with unfavorable outcomes of IgA vasculitis (Henoch-Schönlein purpura) in children: A retrospective study.
    Pediatr Dermatol. 2022 May;39(3):369-371. doi: 10.1111/pde.14927.

  • Li Z, Huang Y, Xu H, Li Z.
    Population pharmacokinetic and dose optimization of mycophenolic acid in children with anti-neutrophilic cytoplasmic antibody-associated nephritis.
    Eur J Clin Pharmacol. 2022 May;78(5):831-838. doi: 10.1007/s00228-021-03265-z. 

  • Finkel R, Honig J, Chao CP, Rescoe E, Solomon S.
    The use of ECMO in pediatric granulomatosis with polyangiitis.
    Pediatr Rheumatol Online J. 2022 May 10;20(1):35. doi: 10.1186/s12969-022-00693-8. PMID: 35538584; PMCID: PMC9092879.

  • Atalay E, Oguz B, Sener S, Nursun Ozcan H, Sag E, Kaya Akca U, Kasap Cuceoglu M, Balik Z, Karakaya J, Karadag O, Basaran O, Batu ED, Bilginer Y, Ozen S.
    A new tool supporting the diagnosis of childhood-onset Behçet's disease: venous wall thickness.
    Rheumatology (Oxford). 2022 May 28:keac314. doi: 10.1093/rheumatology/keac314. Epub ahead of print. PMID: 35640152.

ABRIL 2022
  • Aeschlimann FA, Yeung RSM, Laxer RM.
    An Update on Childhood-Onset Takayasu Arteritis
    Front Pediatr. 2022 Apr 13;10:872313. doi: 10.3389/fped.2022.872313. eCollection 2022.

  • Chen A, Mammen C, Guzman J, Al-Abadi E, Benseler SM, Berard RA, Gerstbacher D, Heshin-Bekenstein M, Kim S, Klein-Gitelman M, Chavan PP, James KE, Martin N, McErlane F, Myrup C, Noone DG, Raghuram J, Shenoi S, Sivaraman V, Tanner T, Yeung RSM, Cabral DA, Morishita KA; for ARChiVe Investigators within the PedVas Initiative.
    Wide variation in glucocorticoid dosing in paediatric ANCA-associated vasculitis with renal disease: a paediatric vasculitis initiative study.
    Clin Exp Rheumatol. 2022 May;40(4):841-848. doi: 10.55563/clinexprheumatol/iol4k2. Epub 2022 Apr 1.

MARZO 2022
  • Jelusic M, Sestan M, Giani T, Cimaz R.
    New Insights and Challenges Associated With IgA Vasculitis and IgA Vasculitis With Nephritis-Is It Time to Change the Paradigm of the Most Common Systemic Vasculitis in Childhood?
    Front Pediatr. 2022 Mar 15;10:853724. doi: 10.3389/fped.2022.853724.

  • Kallash M, Vogt BA, Zeid A, Khin E, Najjar M, Aldughiem A, Benoit E, Stotter B, Rheault M, Warejko JK, Daga A.
    The scope of treatment of pediatric IgA vasculitis nephritis and its outcome: a Pediatric Nephrology Research Consortium study
    Pediatr Nephrol. 2022 Mar 2. doi: 10.1007/s00467-022-05496-3. Online ahead of print.

  • Farisogullari B, Cuceoglu MK, Oral H, Yardimci GK, Bilginer Y, Ozen S, Karadag O.
    Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?
    Intern Emerg Med. 2022 Mar 26. doi: 10.1007/s11739-022-02968-0. Online ahead of print.

  • Lei WT, Chang LS, Zeng BY, Tu YK, Uehara R, Matsuoka YJ, et al.
    Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    EBioMedicine. 2022 Mar 16;78:103946. doi: 10.1016/j.ebiom.2022.103946. Online ahead of print.

  • Suzuki T, Michihata N, Yoshikawa T, Saito K, Matsui H, Fushimi K, Yasunaga H.
    Low- versus high-concentration intravenous immunoglobulin for children with Kawasaki disease in the acute phase.
    Int J Rheum Dis. 2022 Mar 8. doi: 10.1111/1756-185X.14309. Online ahead of print.

  • Haslak F, Yildiz M, Sahin S, Adrovic A, Barut K, Kasapcopur O.
    Pediatric Takayasu Arteritis: A Review of the Literature.
    Curr Pediatr Rev. 2022 Mar 4. doi: 10.2174/1573396318666220304205518. Online ahead of print.

  • Sener S, Basaran O, Akca UK, Atalay E, Cuceoglu MK, Balik Z, Aliyev E, Bayindir Y, Batu ED, Hazirolan T, Bilginer Y, Ozen S.
    Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents.
    Rheumatology (Oxford). 2022 Mar 9:keac149. doi: 10.1093/rheumatology/keac149. Online ahead of print

  • Mirouse A, Deltour S, Leclercq D, Squara PA, Pouchelon C, Comarmond C, et al; French Takayasu Network.
    Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis
    Stroke. 2022 Mar 31:101161STROKEAHA121034445. doi: 10.1161/STROKEAHA.121.034445. Online ahead of print.

  • Yashiro-Furuya M, Sato S, Akanuma M, Sato K, Suzuki E, Kanno T, et al.
    Outcome of Rituximab Treatment in Japanese Patients with ANCA-Associated Vasculitis in Daily Clinical Practice: A Two-Center Study in Fukushima, Japan.
    Mod Rheumatol. 2022 Mar 26:roac027. doi: 10.1093/mr/roac027. Online ahead of print.

  • Toyoda T, Yates M, Watts RA.
    Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
    Curr Rheumatol Rep. 2022 Mar 22. doi: 10.1007/s11926-022-01064-8. Online ahead of print.

  • Bhattarai D, Banday AZ, Nori H, Gupta A.
    Mycophenolate mofetil in the treatment of childhood systemic polyarteritis nodosa
    BMJ Case Rep. 2022 Feb 9;15(2):e248477. doi: 10.1136/bcr-2021-248477.

  • Kang Z, Wu W, Xun M, Ding Y, Li Z.
    Henoch-Schönlein Purpura /IgA Vasculitis Complicated by Coronary Artery Aneurysm: A Case Report and Literature Review.
    Front Pediatr. 2022 Feb 3;9:781106. doi: 10.3389/fped.2021.781106.

  • Carmona-Cruz SA, Durán-McKinster LC, García-Romero MT.
    Atypical purpura and other features associated with unfavorable outcomes of IgA vasculitis (Henoch-Schonlein purpura) in children: A retrospective study.
    Pediatr Dermatol. 2022 Feb 17. doi: 10.1111/pde.14927. 

  • Liu Y, Wen M, He Q, Dang X, Feng S, Liu T, Ding X, Li X, He X.
    Lipid metabolism contribute to the pathogenesis of IgA Vasculitis.
    Diagn Pathol. 2022 Feb 11;17(1):28. doi: 10.1186/s13000-021-01185-1.

  • Bhattarai D, Banday AZ, Nori H, Gupta A.
    Mycophenolate mofetil in the treatment of childhood systemic polyarteritis nodosa.
    BMJ Case Rep. 2022 Feb 9;15(2):e248477. doi: 10.1136/bcr-2021-248477.

ENERO 2022
  • Watts RA, Hatemi G, Burns JC, Mohammad AJ.
    Global epidemiology of vasculitis.
    Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.

  • Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
    Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
    Clin Rheumatol. 2022 Jan;41(1):137-145. doi: 10.1007/s10067-021-05881-7.

  • Selamet Tierney ES, Runeckles K, Tremoulet AH, Dahdah N, Portman MA, Mackie AS, Harahsheh AS, Lang SM, Choueiter NF, Li JS, Manlhiot C, Low T, Mathew M, Friedman KG, Raghuveer G, Norozi K, Szmuszkovicz JR, McCrindle BW; International Kawasaki Disease Registry.
    Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
    J Pediatr. 2022 Jan;240:164-170.e1. doi: 10.1016/j.jpeds.2021.08.072.

  • Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Clin Exp Med. 2022 Jan 18. doi: 10.1007/s10238-021-00776-y.

  • Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    J Pediatr. 2022 Jan;240:158-163.e4. doi: 10.1016/j.jpeds.2021.08.065.

  • Aeschlimann FA, Raimondi R, Leiner T, Donato Aquaro G, Saadoun D, Grotenhuis HB.
    Overview of imaging in adult- and childhood-onset Takayasu arteritis.
    J Rheumatol. 2021 Dec 1;jrheum.210368. doi: 10.3899/jrheum.210368. Online ahead of print.

  • Q Guo, Hu X, Song C, Ren X et al.
    Clinical characteristics and associating risk factors of gastrointestinal perforation in children with IgA vasculitis.
    Ann Med. 2021 Dec;53(1):2315-2320. doi: 10.1080/07853890.2021.2009554.

  • Berti A, Alsawas M, Jawaid T, Prokop LJ, Lee JM et al.
    Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: A systematic review and meta-analysis.
    Nephrol Dial Transplant. 2021 Dec 15;gfab357. doi: 10.1093/ndt/gfab357. Online ahead of print.

  • Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF et al.
    Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
    Lancet Child Adolesc Health. 2021 Dec;5(12):852-861. doi: 10.1016/S2352-4642(21)00270-4. Epub 2021 Oct 27.

  • Sharma C, Ganigara M, Galeotti C, Burns J et al.
    Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.
    Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.

  • Hu J, Ren W.
    Analysis of the Risk Factors in Prognosis of Kawasaki Disease with Coronary Artery Lesions.
    Front Pediatr. 2021 Dec 7;9:798148. doi: 10.3389/fped.2021.798148. eCollection 2021.

  • Ishikawa T, Wada Y, Namba H, Kawai T.
    Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.
    Clin Rheumatol. 2021 Dec;40(12):5019-5024. doi: 10.1007/s10067-021-05822-4. Epub 2021 Jun 19.

  • Sugihara T, Nakaoka Y, Uchida HA, Yoshifuji H, Maejima Y, Watanabe Y, et al.
    Establishing Clinical Remission Criteria and the Framework of a Treat-To-Target Algorithm for Takayasu arteritis: Results of a Delphi Exercise Carried out by an Expert Panel of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for intractable vasculitis.
    Mod Rheumatol. 2021 Nov 27:roab081. doi: 10.1093/mr/roab081. Epub ahead of print.

  • Poisson KE, Zygmunt A, Leino D, Fuller CE, Jones BV, Haslam D, Staat MA, Clay G, Ting TV, Wesselkamper K, Hallinan B, Standridge S, Day ME, McNeal M, Stevenson CB, Vawter-Lee M.
    Lethal Pediatric Cerebral Vasculitis Triggered by Severe Acute Respiratory Syndrome Coronavirus 2.
    Pediatr Neurol. 2021 Nov 12;127:1-5. doi: 10.1016/j.pediatrneurol.2021.11.003. Epub ahead of print.

  • Chu C, He L, Lin YX, Xie LP, Liu F.
    Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report.
    Pediatr Rheumatol Online J. 2021 Nov 8;19(1):157. doi: 10.1186/s12969-021-00643-w.

OCTUBRE 2021  
  • Keenan P, Brunner J, Quan AS, Smitka M, Hahn G, Pain CE, Häfner R, Speth F, Gerstl L, Hedrich CM.
    Diagnosis and Treatment of Small Vessel Childhood Primary Angiitis of the Central Nervous System (sv-cPACNS): An International Survey.
    Front Pediatr. 2021 Oct 12;9:756612. doi: 10.3389/fped.2021.756612. eCollection 2021.

  • Mizerska-Wasiak M, Turczyn A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Drożdż D, et al
    IgA vasculitis nephritis clinical course and kidney biopsy - national study in children.
    Pediatr Rheumatol Online J. 2021 Oct 7;19(1):150. doi: 10.1186/s12969-021-00616-z.

  • Meng T, Shen C, Tang R, Lin W, Ooi JD, Eggenhuizen PJ, et al.
    Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients.
    Clin Exp Med. 2021 Sep 22. doi: 10.1007/s10238-021-00762-4. Online ahead of print.

  • Hou L, Zhang Z, Du Y.
    Leflunomide therapy for IgA vasculitis with nephritis in children.
    BMC Pediatr. 2021 Sep 8;21(1):391. doi: 10.1186/s12887-021-02866-y.

  •  Mizerska-Wasiak M, Turczyn A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Drożdż D, et al
    IgA vasculitis nephritis clinical course and kidney biopsy - national study in children.
    Pediatr Rheumatol Online J. 2021 Oct 7;19(1):150. doi: 10.1186/s12969-021-00616-z.

  • Fung SG, Webster R, Kuenzig ME, Knight B, Batthish M, Robinson C, Chanchlani R, Benchimol EI, Jimenez-Rivera C.
    Incidence of Chronic Immune-Mediated Inflammatory Diseases After Diagnosis with Kawasaki Disease: A Population-Based Cohort Study.
    Rheumatology (Oxford). 2021 Sep 8:keab680. doi: 10.1093/rheumatology/keab680. Online ahead of print.

  •  Watanabe K, Suzuki H, Jiang M, Tsukano S, Kataoka S, Ito S, Sakai T, Hirokawa T, Haniu H, Numano F, Hoshina S, Hasegawa S, Matsunaga M, Chiba K, Saito N, Yoshida H, Takami S, Okubo S, Hirano H, Saitoh A, Bujo H.
    Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.
    Circ J. 2021 Sep 16. doi: 10.1253/circj.CJ-20-1271. Online ahead of print.

  • Darby JB, Jackson JM.
    Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.
    Am Fam Physician. 2021 Sep 1;104(3):244-252.

  • Porritt RA, Zemmour D, Abe M, Lee Y, Meena Narayanan M, Teixeira de Carvalho T, et al.
    NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis.
    Circ Res. 2021 Sep 14. doi: 10.1161/CIRCRESAHA.121.319153. Online ahead of print.

  • Yanagimachi M, Fukuda S, Tanaka F, Iwamoto M, Takao C, Oba K, et al.
    Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease.
    PLoS One. 2021 Sep 9;16(9):e0257138. doi: 10.1371/journal.pone.0257138. eCollection 2021.

  • Su Q, Jiang L, Chai J, Dou Z, Rong Z, Zhao X, Yu B, Wang Y, Wang X.
    Changes of Peripheral Blood Lymphocyte Subsets and Immune Function in Children with Henoch-Schonlein Purpura Nephritis.
    Iran J Immunol. 2021 Sep;18(3):221-225. doi: 10.22034/iji.2021.89742.1964.

  • Chen XQ, Tu L, Zou JS, Zhu SQ, Zhao YJ, Qin YH.
    The Involvement of Neutrophil Extracellular Traps in Disease Activity Associated With IgA Vasculitis.
    Front Immunol. 2021 Sep 3;12:668974. doi: 10.3389/fimmu.2021.668974. eCollection 2021.

  • Yuan Y, Liu J, Zhou Y, Du X, Chen Q, Zhou J, Hou M.
    The relationship between monocyte-to-lymphocyte ratio and the risk of gastrointestinal system involvement in children with IgA vasculitis: A preliminary report.
    Adv Clin Exp Med. 2021 Sep 6. doi: 10.17219/acem/138906. Online ahead of print.

AGOSTO 2021  
  • Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al
    2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
    Arthritis Rheumatol. 2021 Aug;73(8):1349-1365. doi: 10.1002/art.41774

  • Chung SA, Gorelik M, Langford CA, Maz M, Abril A, Guyatt G, et al.
    2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.
    Arthritis Care Res (Hoboken). 2021 Aug;73(8):1061-1070. doi: 10.1002/acr.24633

  • Mosakowska M, Kania DB, Szamotulska K, Rymarz A, Niemczyk S.
    Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.
    MC Nephrol. 2021 Aug 26;22(1):290. doi: 10.1186/s12882-021-02495-8.

  • Su Q, Liang Y, Wang NA, Dou Z, Rong Z, Zhao X, Yu BO, Wang Y, Wang X.
    Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience.
    Turk J Med Sci. 2021 Aug 16. doi: 10.3906/sag-2104-319. Online ahead of print.

  • Oñate I, Ortiz M, Suso A, Mon C, Galindo K, Lentisco C, Camacho R, Sánchez M, Oliet A, Ortega O, Herrero JC, Cortés JA, Pascual A.
    Vasculitis IgA con nefritis (purpura de Schönlein-Henoch) tras COVID-19: una serie de casos y revisión de la literatura.
    Nefrologia. 2021 Aug 3. doi: 10.1016/j.nefro.2021.07.009. Online ahead of print.

  • Grasa CD, Fernández-Cooke E, Sánchez-Manubens J, Carazo-Gallego B, Aracil-Santos J, Anton J, et al.
    Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort.
    Eur J Pediatr. 2021 Aug 30. doi: 10.1007/s00431-021-04215-8. Online ahead of print.

  • Selamet Tierney ES, Runeckles K, Tremoulet AH, Dahdah N, Portman MA, Mackie AS,
    Variation in Pharmacological Management of Kawasaki Patients with Coronary Artery Aneurysms.
    J Pediatr. 2021 Aug 30:S0022-3476(21)00857-X. doi: 10.1016/j.jpeds.2021.08.072. Online ahead of print.

  • Rodriguez-Smith JJ, Verweyen EL, Clay GM, Esteban YM, de Loizaga SR, Baker EJ, Do T, Dhakal S, Lang SM, Grom AA, Grier D, Schulert GS.
    Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
    Lancet Rheumatol. 2021 Aug;3(8):e574-e584. doi: 10.1016/S2665-9913(21)00139-9. 

  • Zhu YP, Shamie I, Casey Lee J, Nowell CJ, Peng W, Angulo S, et al.
    Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
    J Clin Invest. 2021 Aug 31:147076. doi: 10.1172/JCI147076. Online ahead of print.

  • Phamduy TT, Smith S, Herbst KW, Phamduy PT, Brimacombe M, Hogan AH, Salazar JC, Sturm J.
    Kawasaki Disease Hospitalizations in the United States 2016-2020: A Comparison of Before and During the Coronavirus Disease 2019 Era.
    Pediatr Infect Dis J. 2021 Aug 10. doi: 10.1097/INF.0000000000003289. Online ahead of print.

JULIO 2021 
  • Li J, Chen M, Wang J, Lu L, Li X, Le Y.
    MicroRNA profiling in Chinese children with Henoch-Schonlein purpura and association between selected microRNAs and inflammatory biomarkers.
    Acta Paediatr. 2021 Jul;110(7):2221-2229. doi: 10.1111/apa.15789. Epub 2021 Feb 12. PMID: 33533510.

  • Pilania RK, Jindal AK, Johnson N, Prithvi A, Vignesh P, Suri D, Rawat A, Gupta A, Singh S.
    Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
    Rheumatology (Oxford). 2021 Jul 1;60(7):3413-3419. doi: 10.1093/rheumatology/keaa715. PMID: 33221920.

JUNIO 2021  
  • Paul Brogan, Rae S M Yeung, Gavin Cleary et al.
    Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
    Arthritis Rheumatol. 2021 Jun 23. doi: 10.1002/art.41901. Online ahead of print.

  • Mario Sestan, Sasa Srsen, Nastasia Kifer et al.
    Persistence and Severity of Cutaneous Manifestations in IgA Vasculitis Is Associated with Development of IgA Vasculitis Nephritis in Children.
    Dermatology. 2021 Jun 7;1-7. doi: 10.1159/000516765. Online ahead of print.

  • Vanessa Sancho-Shimizu, Petter Brodin, Aurélie Cobat, Catherine M Biggs et al. 
    SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
    J Exp Med. 2021 Jun 7;218(6):e20210446. doi: 10.1084/jem.20210446.

  • Jae Hui Park, Hee Joung Choi.
    Clinical implications of thrombocytosis in acute phase Kawasaki disease.
    Eur J Pediatr. 2021 Jun;180(6):1841-1846. doi: 10.1007/s00431-021-03966-8. Epub 2021 Feb 1.

  • Muserref Kasap Cuceoglu, Seher Sener, Ezgi Deniz Batu et al.
    Systematic review of childhood-onset polyarteritis nodosa and DADA2.
    Semin Arthritis Rheum. 2021 Jun;51(3):559-564. doi: 10.1016/j.semarthrit.2021.04.009. Epub 2021 Apr 19.

  • Rotem Semo Oz, Oluwakemi Onajin, Liora Harel, Rotem Tal, Tomas Dallos, Adena Rosenblatt, Lukas Plank, Linda Wagner-Weiner.
    Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis.
    Pediatr Rheumatol Online J. 2021 Jun 5;19(1):81. doi: 10.1186/s12969-021-00564-8.

  • Takashi Ishikawa, Yasuyuki Wada, Hiroyuki Namba, Toshinao Kawai.
    Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.
    Clin Rheumatol. 2021 Jun 19. doi: 10.1007/s10067-021-05822-4. Online ahead of print.

  • Yukako Yoshikane, Yoshiaki Okuma, Tatsuki Miyamoto et al.
    Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
    Pediatr Rheumatol Online J. 2021 Jun 5;19(1):82. doi: 10.1186/s12969-021-00562-w.

  • Xuting Zhang, Yuee He, Yiping Shao, Biyao Hang, Zhipeng Xu, Maoping Chu.
    Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Pediatr Rheumatol Online J. 2021 Jun 26;19(1):96. doi: 10.1186/s12969-021-00589-z.

MAYO 2021 
  • Calatroni M, Consonni F, Allinovi M, Bettiol A, Jawa N, Fiasella S, et al.
    Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood.
    Clin J Am Soc Nephrol. 2021 May 26:CJN.19181220. doi: 10.2215/CJN.19181220. Online ahead of print.

  • Wilson L, Chandran A, Fudge JC, Moguillansky D, Thatayatikom A, Philip J, Jacobs JP, Bleiweis M, Elder M, Gupta D.
    Takayasu's arteritis presenting as acute myocardial infarction: case series and review of literature.
    Cardiol Young. 2021 May 21:1-4. doi: 10.1017/S1047951121001700. Online ahead of print.

  •  Jackson H, Menikou S, Hamilton S, McArdle A, Shimizu C, Galassini R, et al On Behalf Of The Perform Consortium.
    Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic Profiles.
    Int J Mol Sci. 2021 May 26;22(11):5655. doi: 10.3390/ijms22115655.

  •  Williams CEC, Toner A, Wright RD, Oni L.
    A systematic review of urine biomarkers in children with IgA vasculitis nephritis.
    Pediatr Nephrol. 2021 May 15. doi: 10.1007/s00467-021-05107-7. Online ahead of print.

ABRIL 2021
  • Sota J, Rigante D, Lopalco G, Emmi G, Gentileschi S, Gaggiano C, Ciarcia L, Berlengiero V, Mourabi M, Ricco N, Barneschi S, Mattioli I, Tosi GM, Frediani B, Tarsia M, di Scala G, Vitale A, Iannone F, Fabiani C, Cantarini L.
    Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.
    Intern Emerg Med. 2021 Apr 9. doi: 10.1007/s11739-021-02725-9. Online ahead of print.

  • Wu J, Pei Y, Rong L, Zhuang H, Zeng S, Chen L, Jiang X.
    Clinicopathological Analysis of 34 Cases of Primary Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Chinese Children.
    Front Pediatr. 2021 Apr 26;9:656307. doi:10.3389/fped.2021.656307

 MARZO 2021 
  • Morishita KA, Wagner-Weiner L, Yen EY, Sivaraman V, James KE, Gerstbacher D, et al; CARRA ANCA-Associated Vasculitis Workgroup.
    Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Arthritis Care Res (Hoboken). 2021 Mar 6. doi: 10.1002/acr.24590. Online ahead of print.

  • Hoggart C, Shimizu C, Galassini R, Wright VJ, Shailes H, Bellos E, et al; International Kawasaki Disease Genetics Consortium; UK Kawasaki Disease Genetics Consortium; EUCLIDS Consortium.
    Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease.
    Eur J Hum Genet. 2021 Mar 26:1-11. doi: 10.1038/s41431-021-00838-5. Online ahead of print.

  • Wang Y, Xu Y, Huang P, Che D, Wang Z, Huang X, Xie X, Li W, Zhang L, Gu X.
    Homozygous of MRP4 Gene rs1751034 C Allele Is Related to Increased Risk of Intravenous Immunoglobulin Resistance in Kawasaki Disease.
    Front Genet. 2021 Mar 15;12:510350. doi: 10.3389/fgene.2021.510350.

  • Suzuki T, Kakimoto N, Tsuchihashi T, Suenaga T, Takeuchi T, Shibuta S, et al.
    Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
    Eur J Pediatr. 2021 Mar 24. doi: 10.1007/s00431-021-04006-1. Online ahead of print.

  • Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, et al; Rheumatology Study Group of the Italian Pediatric Society.
    Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Pediatr Rheumatol Online J. 2021 Mar 16;19(1):29. doi: 10.1186/s12969-021-00511-7.

  • Robinson C, Chanchlani R, Gayowsky A, Brar S, Darling E, Demers C, et al.
    Incidence and short-term outcomes of Kawasaki disease.
    Pediatr Res. 2021 Mar 30. doi: 10.1038/s41390-021-01496-5. Online ahead of print.

  • Clemente G, Pereira RMR, Aikawa N, Silva CA, Campos LMA, Alves G, et al.
    Is PET/MRI a reliable tool for detecting vascular activity in treated childhood-onset Takayasu´s arteritis (C-TA)? A multicenter study.
    Rheumatology (Oxford). 2021 Mar 15:keab255. doi: 10.1093/rheumatology/keab255. Online ahead of print.

  • Tekgöz N, Aydın F, Kurt T, Sezer M, Tekin Z, Karagöl C, Çakar N, Acar B.
    Clinical features and outcomes of childhood polyarteritis nodosa: A single referral center experience.
    Mod Rheumatol. 2021 Mar 1:1-10. doi: 10.1080/14397595.2021.1886892. Online ahead of print.

  • Gibson KM, Kain R, Luqmani RA, Ross CJ, Cabral DA, Brown KL.
    Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis
    Front Immunol. 2021 Feb 3;11:624758. doi: 10.3389/fimmu.2020.624758. eCollection 2020.

  • Tekgöz N, Aydın F, Kurt T, Sezer M, Tekin Z, Karagöl C, Çakar N, Acar B
    Clinical features and outcomes of childhood polyarteritis nodosa: A single referral center experience.
    Mod Rheumatol. 2021 Mar 1:1-10. doi: 10.1080/14397595.2021.1886892. 

  • Ferreira D, Ng R, Lai E, Singh-Grewal D, Kehr J, Collins N, Thomson Bowe K.
    Kawasaki Disease in the Australian Population: An Australian Tertiary Hospital Experience.
    Heart Lung Circ. 2021 Feb 18:S1443-9506(21)00029-9. doi: 10.1016/j.hlc.2020.12.016.

  • Li C, Du Y, Wang H, Wu G, Zhu X.
    Neonatal Kawasaki disease: Case report and literature review.
    Medicine (Baltimore). 2021 Feb 19;100(7):e24624. doi: 10.1097/MD.0000000000024624.

  • He L, Liu F, Yan W, Huang M, Huang M, Xie L, Guo Y, Xu X, Chu C, Wu L, Liang X, Sun S, Wang F, Zhao L, Zhao Q, Ma X, Xie L, Huang G. 
    Randomized Trial of Different initial IVIG Regimens in Kawasaki Disease.
    Pediatr Int. 2021 Feb 18. doi: 10.1111/ped.14656.

  • Yuan J, Jiang Z, Li M, Li W, Gu X, Wang Z, Pi L, Xu Y, Zhou H, Zhang B, Deng Q, Wang Y, Huang P, Zhang L, Gu X. 
    Integrin α2 gene polymorphism is a risk factor of coronary artery lesions in Chinese children with Kawasaki disease.
    Pediatr Rheumatol Online J. 2021 Feb 8;19(1):12. doi: 10.1186/s12969-021-00494-5.

  • Wu Q, Weng R, Xu Y, Wang L, Huang Y, Yang J.
    Activin a suppresses peripheral CD8(+) T lymphocyte activity in acute-phase Kawasaki disease.
    BMC Immunol. 2021 Feb 23;22(1):17. doi: 10.1186/s12865-021-00407-x.

  • Zhu F, Ang JY.
    2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.
    Curr Infect Dis Rep. 2021;23(3):3. doi: 10.1007/s11908-021-00746-1. Epub 2021 Feb 6.

  • Miyata K, Miura M, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H.
    Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.
    Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007191. doi: 10.1161/CIRCOUTCOMES.120.007191. Epub 2021 Feb 5.

  • Sharma D, Iqbal F, Narayan Dev C, Bora S, Hoque RA, Kom LB.
    Clinical profile, treatment and outcome of Kawasaki disease: A single-center experience from a tertiary care referral center of Assam, north-east India.
    Int J Rheum Dis. 2021 Feb 1. doi: 10.1111/1756-185X.14059. 

  • van Stijn-Bringas Dimitriades D, Planken N, Kuipers I, Kuijpers T.
    CT Angiography or Cardiac MRI for Detection of Coronary Artery Aneurysms in Kawasaki Disease.
    Front Pediatr. 2021 Feb 4;9:630462. doi: 10.3389/fped.2021.630462. eCollection 2021.

  • Koskela M, Nihtilä J, Ylinen E, Kolho KL, Nuutinen M, Ritari J, Jahnukainen T.
    HLA-DQ and HLA-DRB1 alleles associated with Henoch-Schonlein purpura nephritis in Finnish pediatric population: a genome-wide association study.
    Pediatr Nephrol. 2021 Feb 16. doi: 10.1007/s00467-021-04955-7. 

  • Demir AM, Aydin F, Acar B, Kurt T, Poyraz A, Kiremitci S, Gülleroglu B, Azili MN, Bayrakci US.
    IgG4-related disease and ANCA positive vasculitis in childhood: a case-based review.
    Clin Rheumatol. 2021 Feb 15. doi: 10.1007/s10067-021-05635-5.

  • Cuceoglu MK, Ozen S.
    Pulmonary Manifestations of Systemic Vasculitis in Children.
    Pediatr Clin North Am. 2021 Feb;68(1):167-176. doi: 10.1016/j.pcl.2020.09.014.

  • Karabacak M, Kaymaz-Tahra S, Şahin S, Yıldız M, Adroviç A, Barut K, Direskeneli H, Kasapçopur Ö, Alibaz-Öner F.
    Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey.
    Semin Arthritis Rheum. 2021 Feb;51(1):192-197. doi: 10.1016/j.semarthrit.2020.10.013. Epub 2020 Dec 29.

  • Sönmez HE, Demir F, Özdel S, Karadağ ŞG, Bağlan E, Bülbül M, Çakan M, Ayaz NA, Sözeri B.
    Neuroimaging of Children With Takayasu Arteritis.
    J Child Neurol. 2021 Feb 16:883073821991287. doi: 10.1177/0883073821991287. 

ENERO 2021
  • Koné-Paut I, Tellier S, Belot A, Brochard K, Guitton C, Marie I, Meinzer U, Cherqaoui B, Galeotti C, Boukhedouni N, Agostini H, Arditi M, Lambert V, Piedvache C.
    Phase II Open-Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease.
    Arthritis Rheumatol. 2021; 73(1):151-161. doi: 10.1002/art.41481.

  •  Maccora I, Calabri GB, Favilli S, Brambilla A, Trapani S, Marrani E, Simonini G.
    Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome.
    Eur J Pediatr. 2021 Jan;180(1):271-275. doi: 10.1007/s00431-020-03712-6. Epub 2020 Jun 15. PMID: 32556506.

  •  Kurt T, Aydın F, Sezer M, Tekgöz PN, Tekin ZE, Çelikel E, Karagöl C, Coşkun S, Acar B.
    Performance of diagnostic criteria in pediatric Behçet's disease.
    Rheumatol Int. 2021 Jan 15. doi: 10.1007/s00296-020-04777-0. Epub ahead of print. PMID: 33449161.

  • Guzelkucuk Z, Gurlek Gokcebay D, Arman Bilir O, Basaran O, Celikel Acar B, Ozbek NY, Yarali N.
    Children With Behçet Disease-associated Thrombosis: A Single-Center Experience.
    J Pediatr Hematol Oncol. 2021 Jan;43(1):e15-e18. doi: 10.1097/MPH.0000000000001877. PMID: 32604332.

  • Guzelkucuk Z, Gurlek Gokcebay D, Arman Bilir O, Basaran O, Celikel Acar B, Ozbek NY, Yarali N.
    Children With Behçet Disease-associated Thrombosis: A Single-Center Experience.
    J Pediatr Hematol Oncol. 2021 Jan;43(1):e15-e18. doi: 10.1097/MPH.0000000000001877. PMID: 32604332.

  • Lawton A, Machta J, Semple T, Gupta A.
    Pulmonary manifestations of systemic vasculitis in childhood.
    Breathe (Sheff). 2020 Dec;16(4):200211

  • McMurray JC, May JW, Cunningham MW, Jones OY.
    Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.
    Front Pediatr. 2020 Dec 16;8:626182

  • Sinha A, Nayak S, Dehuri P, Kanungo S, Pati S.
    Clinico-epidemiological characteristics of Kawasaki-like disease in paediatric patients with COVID-19: a protocol for rapid living systematic review.
    BMJ Open. 2020 Dec 24;10(12):e041160

  • Lim KYY, Chua MC, Tan NWH, Chandran S.
    Reactivation of BCG inoculation site in a child with febrile exanthema of 3 days duration: an early indicator of incomplete Kawasaki disease.
    BMJ Case Rep. 2020 Dec 17;13(12):e239648

  • Toubiana J, Levy C, Allali S, Jung C, Leruez-Ville M, Varon E, Bajolle F, Ouldali N, Chareyre J, Béchet S, Elbez A, Casanova JL, Chalumeau M, Cohen R, Cohen JF.
    Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case-control study, Paris, France, April to May 2020.
    Euro Surveill. 2020 Dec;25(48):2001813

  • Berardicurti O, Conforti A, Ruscitti P, Cipriani P, Giacomelli R.
    The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
    Expert Rev Clin Immunol. 2020 Dec;16(12):1205-1215

  • Akca UK, Kesici S, Ozsurekci Y, Aykan HH, Batu ED, Atalay E, Demir S, Sag E, Vuralli D, Bayrakci B, Bilginer Y, Ozen S.
    Kawasaki-like disease in children with COVID-19.
    Rheumatol Int. 2020 Dec;40(12):2105-2115

  • Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, Tarquinio KM, Basu RK, Kao C, Linam WM, Zimmerman MG, Shi PY, Menachery VD, Oster ME, Edupuganti S, Anderson EJ, Suthar MS, Wrammert J, Jaggi P.
    Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Pediatrics. 2020 Dec;146(6):e2020018242

  • Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.
    Concurrent chilblains and retinal vasculitis in a child with COVID-19.
    J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e764-e766

  • Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.
    Concurrent chilblains and retinal vasculitis in a child with COVID-19.
    J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e764-e766

  • Liao CH, Tsai M, Yang YH, Chiang BL, Wang LC.
    Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study.
    Pediatr Rheumatol Online J. 2020 Nov 10;18(1):86.
  • Sayad E, Vogel TP, Cortes-Santiago N, Patel KR, McNeill DM, Spielberg D, Silva-Carmona M.
    Lung biopsy in the diagnosis of pediatric ANCA-associated vasculitis.
    Pediatr Pulmonol. 2020 Nov 4. doi: 10.1002/ppul.25151
  • Javadi Parvaneh V, Shirzani A, Rahmani K, Shiari R.
    Pediatric Granulomatosis With Polyangiitis Mimicking IgA Vasculitis: A Case Report.
    Clin Med Insights Arthritis Musculoskelet Disord. 2020 Nov 2;13:1179544120967371. doi: 10.1177/1179544120967371
  • Pilania RK, Jindal AK, Johnson N, Prithvi A, Vignesh P, Suri D, Rawat A, Gupta A, Singh S.
    Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
    Rheumatology (Oxford). 2020 Nov 22:keaa715. doi: 10.1093/rheumatology/keaa715
  • Morishita KA, Goldman RD.
    Current Approach to the Evaluation and Management of Incomplete Kawasaki Disease in the Emergency Department.
    Pediatr Emerg Care. 2020 Nov;36(11):537-541.
  • Yeo WS, Ng QX.
    Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
    Med Hypotheses. 2020 Nov;144:110263. doi: 10.1016/j.mehy.2020.110263
  • Ekinci RMK, Esen E, Erol AH, Sızmaz S, Karagoz D, Altintas DU, Balcı S.
    Evaluation of different classification criteria in children with Behcet disease: results from a single referral center.
    Expert Rev Clin Immunol. 2020 Oct 23:1-5. doi: 10.1080/1744666X.2021.1834853. Online ahead of print.
  • Bolek EC, Kaya Akca U, Sari A, Sag E, Demir S, Kilic L, Sener YZ, Aykan HH, Kaya EB, Bilginer Y, Akdogan A, Kiraz S, Karadag O, Ozen S.
    Is Takayasu's arteritis more severe in children?
    Clin Exp Rheumatol. 2020 Sep 16. Online ahead of print.

  • Mekinian A, Saadoun D, Vicaut E, Thietart S, Lioger B, Jego P, et al; French Takayasu network.
    Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial.
    Arthritis Res Ther. 2020 Sep 17;22(1):218. doi: 10.1186/s13075-020-02311-y

  • Goel R, Chandan JS, Thayakaran R, Adderley NJ, Nirantharakumar K, Harper L.
    Cardiovascular and renal morbidity in Takayasu arteritis: a population-based retrospective cohort study from UK
    Arthritis Rheumatol. 2020 Sep 23. doi: 10.1002/art.41529. Online ahead of print.

  • Schäfer VS, Jin L, Schmidt WA.
    Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides.
    Curr Rheumatol Rep. 2020 Sep 21;22(11):76. doi: 10.1007/s11926-020-00955-y

  • Schmidt WA, Nielsen BD.
    Imaging in large-vessel vasculitis.
    Best Pract Res Clin Rheumatol. 2020 Sep 15:101589. doi: 10.1016/j.berh.2020.101589. Online ahead of print.

  • Akiyama M, Kaneko Y, Takeuchi T.
    Tocilizumab for the treatment of polyarteritis nodosa: a systematic literature review.
    Ann Rheum Dis. 2020 Sep 9:annrheumdis-2020-218710. doi: 10.1136/annrheumdis-2020-218710. Online ahead of print.

  • Tang M, Zhang X, Li X, Lei L, Zhang H, Ling C, Ni J, Lv J, Liu X, Chen X.
    Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
    Clin Exp Nephrol. 2020 Sep 15. doi: 10.1007/s10157-020-01968-8. Online ahead of print.

  • Alonso de la Hoz J, Martínez Antequera CE, Fernández Manso B, Llorente Otones L, de Inocencio Arocena J.
    Vasculitis IgA (purpura de Schönlein-Henoch) hemorrágico-ampollosa ¿tiene peor pronóstico?
    Reumatol Clin. 2020 Sep 3:S1699-258X(20)30195-9. doi: 10.1016/j.reuma.2020.07.011. Online ahead of print.

  • Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newberger JW
    Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Arch Dis Child. 2020 Sep 17:archdischild-2020-319810. doi: 10.1136/archdischild-2020-319810. Online ahead of print.

  • Burns JC, DeHaan LL, Shimizu C, Bainto EV, Tremoulet AH, Cayan DR, Burney JA.
    Temporal Clusters of Kawasaki Disease Cases Share Distinct Phenotypes That Suggest Response to Diverse Triggers.
    J Pediatr. 2020 Sep 22:S0022-3476(20)31176-8. doi: 10.1016/j.jpeds.2020.09.043. Online ahead of prin

  • Padilla LA, Collins JL, Idigo AJ, Lau Y, Portman MA, Shrestha S.
    Kawasaki Disease and Clinical Outcome Disparities among Black Children.
    J Pediatr. 2020 Sep 24:S0022-3476(20)31244-0. doi: 10.1016/j.jpeds.2020.09.052. Online ahead of print.

  • Corwin DJ, Sartori LF, Chiotos K, Odom John AR, Cohn K, Bassiri H, Behrens EM, Teachey DT, Henrickson SE, Diorio CJ, Zorc JJ, Balamuth F.
    Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic.
    Pediatr Emerg Care. 2020 Sep 22. doi: 10.1097/PEC.0000000000002248. Online ahead of print.

  • Zhao X, Wen Q, Qiu Y, Huang F.
    Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Rheumatol Int. 2020 Sep 22. doi: 10.1007/s00296-020-04704-3. Online ahead of print.

  • Bala MM, Malecka-Massalska TJ, Koperny M, Zajac JF, Jarczewski JD, Szczeklik W.
    Anti-cytokine targeted therapies for ANCA-associated vasculitis.
    Cochrane Database Syst Rev. 2020 Sep 29;9:CD008333. doi: 10.1002/14651858.CD008333.pub2.

  • Thompson GE, Fussner LA, Hummel AM, Schroeder DR, Silva F, Snyder MR, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U.
    Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.
    Front Immunol. 2020 Sep 3;11:2053. doi: 10.3389/fimmu.2020.020

  • Chen J, Yue Y, Wang L, Deng Z, Yuan Y, Zhao M, Yuan Z, Tan C, Cao Y.
    Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease.
    Sci Rep . 2020 Sep 3;10(1):14525. doi: 10.1038/s41598-020-71371-6.

  • Sršen S, Frković M, Malčić I, Jelušić M
    Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia
    Acta Dermatovenerol Croat. 2020 Aug;28(2):63-69.
  • Karadağ ŞG, Çakmak F, Çil B, Tanatar A, Sönmez HE, Kıyak A, Yavuz S, Çakan M, Aktay Ayaz N.
    The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch-Schönlein Purpura.
    Postgrad Med. 2020 Aug 19:1-6. doi: 10.1080/00325481.2020.1807161.
  • Paek EY, Yi DY, Kang B, Choe BH.
    Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch-Schönlein purpura patients: a retrospective analysis.
    BMC Pediatr. 2020 Aug 8;20(1):374. doi: 10.1186/s12887-020-02263-x.
  • Chen X, Hou Y, Chen C, Jiang G.
    The predictive value of β2-microglobulin for steroid resistance in children with Henoch-Schönlein purpura nephritis
    Int J Dermatol. 2020 Aug 7. doi: 10.1111/ijd.15052.
  • Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, et al.
    Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    J Pediatr. 2020 Aug 15;S0022-3476(20)31018-0.
JULIO 2020
  • Liu X, Zhou K, Hua Y, Wu M, Liu L, Shao S, Wang C.
    Neurological involvement in Kawasaki disease: a retrospective study.
    Pediatr Rheumatol Online J. 2020 Jul 14;18(1):61. doi: 10.1186/s12969-020-00452-7.

  • Smitka M, Bruck N, Engellandt K, Hahn G, Knoefler R, von der Hagen M.
    Clinical Perspective on Primary Angiitis of the Central Nervous System in Childhood (cPACNS).
    Front Pediatr. 2020 Jul 3;8:281. doi: 10.3389/fped.2020.00281. eCollection 2020.

  • Fan L, Yang L, Wei D, Ma W, Lou Y, Song L, Bian J, Zhang H, Cai J.
    Clinical Scenario and Long-term Outcome of Childhood Takayasu Arteritis Undergoing 121 Endovascular Interventions: The Largest Cohort over a 15-year Period.
    Arthritis Care Res (Hoboken). 2020 Jul 23. doi: 10.1002/acr.24387. Epub ahead of print.

  • Noval Rivas M, Arditi M.
    Kawasaki disease: pathophysiology and insights from mouse models.
    Nat Rev Rheumatol. 2020;16(7):391-405. doi:10.1038/s41584-020-0426-0

JUNIO 2020
  • Ganhão S, Loureiro GB, Oliveira DR, Dos-Reis-Maia R, Aguiar F, Quental R, Moura C, Barreira JL, Rodrigues M, Brito I.
    Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
    Clin Rheumatol. 2020 Jun 13. doi: 10.1007/s10067-020-05210-4.

  • Guzelkucuk Z, Gurlek Gokcebay D, Arman Bilir O, Basaran O, Celikel Acar B, Ozbek NY, Yarali N.
    Children With Behçet Disease-associated Thrombosis: A Single-Center Experience.
    J Pediatr Hematol Oncol. 2020 Jun 26. doi: 10.1097/MPH.0000000000001877.

MAYO 2020
  • Zheng C, Childers J, Rabinovich E, Nazareth-Pidgeon K.
    Recurrent Henoch-Schönlein Purpura with bullous rash and pulmonary nodules.
    Pediatr Rheumatol Online J. 2020 May 24;18(1):40.
  • Viner RM, Whittaker E.
    Kawasaki-like disease: emerging complication during the COVID-19 pandemic.
    Lancet. 2020 May 13.
  • Harahsheh AS, Dahdah N, Newburger JW, Portman MA, Piram M, Tulloh R, McCrindle BW, de Ferranti SD, Cimaz R, Truong DT, Burns JC.
    Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic.
    J Pediatr. 2020 Apr 23:S0022-3476(20)30556-4. doi: 10.1016/j.jpeds.2020.04.052. Online ahead of print.
  • Burns JC, El-Said H, Tremoulet AH, Friedman K, Gordon JB, Newburger JW
    Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease.
    J Pediatr. 2020 Apr 17:S0022-3476(20)30246-8. doi: 10.1016/j.jpeds.2020.02.033. Online ahead of print
MARZO 2020
  • Kolkhir P, Bonnekoh H, Kocatürk E, Hide M, Metz M, Sánchez-Borges M, Krause K, Maurer M.
    Management of urticarial vasculitis: A worldwide physician perspective.
    World Allergy Organ J. 2020 Mar 5;13(3):100107. doi: 10.1016/j.waojou.2020.100107.
  • Kumrah R, Vignesh P, Rawat A, Singh S
    Immunogenetics of Kawasaki disease.
    Clin Rev Allergy Immunol. 2020 Mar 21. doi: 10.1007/s12016-020-08783-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32200494
  • Nomura Y, Yashiro M, Masuda K, Nakamura Y.
    Treatment change and coronary artery abnormality in incomplete Kawasaki disease.
    Pediatr Int. 2020 Mar 27. doi: 10.1111/ped.14242. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32219919
  • Zheng X, Zhang Y, Liu L, Yue P, Wang C, Zhou K, Hua Y, Wu G, Li Y.
    N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease.
    Sci Rep. 2020 Mar 20;10(1):5130.
  • Medeiros R de Magalhães C, Coutinho de Almeida F, Gandolfi L, Pratesi R, Ribeiro de M Alves N, Selleski N, Zandonadi RP, Nakano EY, Pratesi CB.
    Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study.
  • Belkaibech S, Potter BJ, Kang H, Lee GE, Bilodeau-Bertrand M, Auger N.
    Maternal Autoimmune Disorders and Risk of Kawasaki Disease in Offspring.
    J Pediatr. 2020 Mar 11. pii: S0022-3476(20)30172-4. doi: 10.1016/j.jpeds.2020.02.016. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32171556
  • Hao S, Ling XB, Kanegaye JT, Bainto E, Dominguez SR, Heizer H, Jone PN, Anderson MS, Jaggi P, Baker A, Son MB, Newburger JW, Ashouri N, McElhinney DB, Burns JC, Whitin JC, Cohen HJ, Tremoulet AH; Pediatric Emergency Medicine Kawasaki Disease Research Group
    Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses.
    Arch Dis Child. 2020 Mar 5. pii: archdischild-2019-317980. doi: 10.1136/archdischild-2019-317980. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32139365
  • Stojanović VD, Radovanović TD, Koprivšek KM, Vijatov Ðurić GV, Doronjski AD.
    Kawasaki Disease Complicated with Cerebral Vasculitis and Severe Encephalitis.
    Ann Indian Acad Neurol. 2020 Mar-Apr;23(2):228-232.
  • Sun Y, Liu J, Geng Z, Tao Y, Zheng F, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
    Pediatr Rheumatol Online J. 2020 Mar 17;18(1):23. 
  • Maccora I, De Libero C, Simonini G.
    Uveitis and Henoch-Schönlein purpura: case report and literature review.
    Clin Exp Rheumatol. 2020 Mar 5. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32141439
  • Lee KH, Hong SH, Jun J, Jo Y, Jo W, Choi D, Joo J, Jung G, Ahn S, Kronbichler A, Eisenhut M, Shin JI.
    Treatment of Refractory Henoch-Schonlein Purpura (HSP) with Dapsone: A Systematic Review.
    Clin Exp Pediatr. 2020 Feb 6. doi: 10.3345/kjp.2019.00514.
  • Pilania RK, Randhawa MS, Naseem S, Suri D, Singh S.
    Transient Erythroblastopenia: An Unusual Manifestation of Macrophage Activation Syndrome in Kawasaki Disease.
    J Clin Rheumatol. 2020 Feb 22. doi: 10.1097/RHU.0000000000001349.
  • Rivera-Rodriguez L, Pardo-Díaz E, Moreno-Espinosa S, Scheffler-Mendoza S, Ruiz-Ontiveros MA, Garrido-García LM, Iglesias-Amaya A, Yamazaki-Nakashimada MA.
    Use of Infliximab in the Treatment of Macrophage Activation Syndrome Complicating Kawasaki Disease.
    J Pediatr Hematol Oncol. 2020 Feb 19. doi: 10.1097/MPH.0000000000001756.
  • Sudo D, Makino N, Nakamura Y.
    Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan.
    Arch Dis Child. 2020 Feb 27. pii: archdischild-2019-317238. doi: 10.1136/archdischild-2019-317238.
  • Elakabawi K, Lin J, Jiao F, Guo N, Yuan Z.
    Kawasaki Disease: Global Burden and Genetic Background.
    Cardiol Res. 2020 Feb;11(1):9-14. doi: 10.14740/cr993. Epub 2020 Jan 26.
  • Weng H, Pei Q, Yang M, Zhang J, Cheng Z, Yi Q.
    Hypomethylation of C1q/tumor necrosis factor-related protein-1 promoter region in whole blood and risks for coronary artery aneurysms in Kawasaki disease.
    Int J Cardiol. 2020 Feb 3. pii: S0167-5273(19)36023-1. doi: 10.1016/j.ijcard.2020.02.002.
  • Piram M, Darce Bello M, Tellier S, Di Filippo S, Boralevi F, Madhi F, Meinzer U, Cimaz R, Piedvache C, Koné-Paut I.
    Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease.
    Sci Rep. 2020 Feb 20;10(1):3125. doi: 10.1038/s41598-020-59972-7.
  • Chang LS, Kuo HC.
    The role of corticosteroids in the treatment of Kawasaki disease.
    Expert Rev Anti Infect Ther. 2020 Feb;18(2):155-164. doi: 10.1080/14787210.2020.1713752. Epub 2020 Jan 15.
  • Shi R, Luo Y, Li S, Kong M, Liu X, Yu M, Wu J, Huang L, Yang Z.
    Single-nucleotide Polymorphism rs17860041 A/C in the Promoter of the PPIA Gene is Associated with Susceptibility to Kawasaki Disease in Chinese Children.
    Immunol Invest. 2020 Feb 20:1-13. doi: 10.1080/08820139.2020.1727919.
  • Shimada S, Matsuoka D, Murase T, Hachiya A, Motoki N, Nakazawa Y.
    Impact of infliximab administration before plasma exchange therapy on patients with Kawasaki disease.
    Ther Apher Dial. 2020 Feb 19. doi: 10.1111/1744-9987.13486.
  • Ling-Sai C, Guo MM, Yan JH, Huang YH, Lo MH, Kuo HC.
    Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset.
    Pediatr Allergy Immunol. 2020 Feb 19. doi: 10.1111/pai.13235.
  • Rohani P, Imanzadeh F, Sayyari A, Kazemi Aghdam M, Shiari R.
    Persistent elevation of aspartate aminotransferase in a child after incomplete Kawasaki disease: a case report and literature review.
    BMC Pediatr. 2020 Feb 17;20(1):73. doi: 10.1186/s12887-020-1975-8.
  • Sakina S, Owais SS, Khan EA, Sheikh AM.
    Kawasaki disease: Clinical-laboratory spectrum and outcome in a cohort of children treated at a tertiary care hospital in Islamabad, Pakistan.
    Pak J Med Sci. 2020 Jan-Feb;36(2):260-264. doi: 10.12669/pjms.36.2.910.
  • Liu FF, Liu HH, Qiu Z, Wang JJ, Samadli S, Wu Y, Wu YF, Xu Y, Luo HH, Chen WX, Zhang DD, Hu P.
    Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease.
    Eur J Clin Invest. 2020 Feb 15:e13210. doi: 10.1111/eci.13210.
  • Rowley AH, Baker SC, Arrollo D, Gruen LJ, Bodnar T, Innocentini N, Hackbart M, Cruz-Pulido YE, Wylie KM, Kim KA, Shulman ST.
    A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease.
    J Infect Dis. 2020 Feb 13. pii: jiaa066. doi: 10.1093/infdis/jiaa066.
  • Wu G, Yue P, Ma F, Zhang Y, Zheng X, Li Y.
    Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease.
    Medicine (Baltimore). 2020 Feb;99(6):e18535. doi: 10.1097/MD.0000000000018535.
  • Soni PR, Noval Rivas M, Arditi M.
    A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.
    Curr Rheumatol Rep. 2020 Feb 5;22(2):6. doi: 10.1007/s11926-020-0882-1.
  • Porritt RA, Markman JL, Maruyama D, Kocaturk B, Chen S, Lehman TJA, Lee Y, Fishbein MC, Noval Rivas M, Arditi M.
    Interleukin-1 Beta-Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment.
    Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):802-818. doi: 10.1161/ATVBAHA.119.313863. Epub 2020 Jan 30.
  • Gökçe S, Kurugöl Z, Koturoglu G, Aslan A.
    Predictive role of laboratory markers and clinical features for recurrent Henoch-Schönlein Purpura in childhood: A study from Turkey.
    Mod Rheumatol. 2020 Feb 3:1-6. doi: 10.1080/14397595.2019.1690966.
  • Brom M, Gandino IJ, Scolnik M.
    IgA Vasculitis (Henoch-Schönlein Purpura) in Argentina: Comparison Between Pediatric and Adult Populations.
    Mayo Clin Proc. 2020 Feb;95(2):422-424. doi: 10.1016/j.mayocp.2019.11.023.
  • Nagasawa T, Miura K, Kaneko N, Yabuuchi T, Ishizuka K, Chikamoto H, Akioka Y, Hisano M, Hattori M.
    Long-term outcome of renal transplantation in childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Pediatr Transplant. 2020 Mar;24(2):e13656. doi: 10.1111/petr.13656. Epub 2020 Jan 16.
ENERO 2020
  • Liu L, Luo C, Hua Y, Wu M, Shao S, Liu X, Zhou K, Wang C.
    Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study.
    Eur J Pediatr. 2020 Jan 24. doi: 10.1007/s00431-019-03492-8. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31980953
  • Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, Tamura N, Banno S, Yoshifuji H, Sakata Y, Kawakami A, Atsumi T, Furuta S, Kohsaka H, Suzuki K, Hara R, Maejima Y, Tsukamoto H, Takasaki Y, Yamashita K, Okada N, Yamakido S, Takei S, Yokota S, Nishimoto N.
    Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
    Rheumatology (Oxford). 2020 Jan 17. pii: kez630. doi: 10.1093/rheumatology/kez630. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31951279
  • Gómez S, Pérez M, Pellegrini M, Isern E, Quintana C, Artacho P, Bertolini M, Pomerantz B, Gadda N.
    Henoch-Schonlein purpura in pediatrics: Ten years of experience at a moderate risk office of a general hospital.
    Arch Argent Pediatr. 2020 Feb;118(1):31-37. doi: 10.5546/aap.2020.eng.31.
  • Demirkaya E, Arici ZS, Romano M, Berard RA, Aksentijevich I.
    Current State of Precision Medicine in Primary Systemic Vasculitides.
    Front Immunol. 2019 Dec 17;10:2813. doi: 10.3389/fimmu.2019.02813.
  • L'Huillier AG, Brito F, Wagner N, Cordey S, Zdobnov E, Posfay-Barbe KM, Kaiser L.
    Identification of Viral Signatures Using High-Throughput Sequencing on Blood of Patients With Kawasaki Disease.
    Front Pediatr. 2019 Dec 19;7:524.
  • Wallace ZS, Stone JH.
    Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
    Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855
  • Wu S, Long Y, Chen S, Huang Y, Liao Y, Sun Y, Zhang Q, Zhang C, Yan H, Qi J, Liu X, Chen Y, Zhang Y, Du J.
    A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.
    Front Pediatr. 2019 Dec 11;7:514.
  • Panda PK, Sharawat IK.
    Kawasaki Disease Presenting as Febrile Seizure: A Clinical Oddity.
    J Clin Rheumatol. 2019 Dec 27. doi: 10.1097/RHU.0000000000001258
  • Ellacuriaga San Martin J, Geiger PA.
    Takayasu Arteritis Type V.
    Eur J Vasc Endovasc Surg. 2019 Dec 18. pii: S1078-5884(19)32629-2
  • Tirelli F, Marrani E, Giani T, Cimaz R.
    One year in review: Kawasaki disease
    Curr Opin Rheumatol. 2019 Oct 9. doi: 10.1097/BOR.0000000000000671. [Epub ahead of print]
  • Kainth R, Shah P.
    Kawasaki disease: origins and evolution
    Arch Dis Child. 2019 Oct 18. pii: archdischild-2019-317070. doi: 10.1136/archdischild-2019-317070. [Epub ahead of print]
  • Rahne T, Plontke S, Keyßer G.
    Vasculitis and the ear: a literature review.
    Curr Opin Rheumatol. 2019 Oct 9. doi: 10.1097/BOR.0000000000000665. [Epub ahead of print]
  • Ekinci RMK, Balci S, Melek E, Karabay Bayazit A, Dogruel D, Altintas DU, Yilmaz M.
    Clinical manifestations and outcomes of 420 children with Henoch Schönlein Purpura from a single referral center from Turkey: a three-year experience
    Mod Rheumatol. 2019 Oct 29:1-19. doi: 10.1080/14397595.2019.1687074. [Epub ahead of print]
  • Do N, Ringold S, Brandling-Bennett H.
    Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review
    Pediatr Dermatol. 2019 Oct 2. doi: 10.1111/pde.14005. [Epub ahead of print]
  • Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, Printz B, Dominguez SR, Heizer H, Anderson MS, Glodé MP, He F, Padilla RL, Shimizu C, Bainto E, Pancheri J, Cohen HJ, Whitin JC, Burns JC.
    Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.
    J Pediatr. 2019 Sep 24. pii: S0022-3476(19)30972-2. doi: 10.1016/j.jpeds.2019.07.064. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31561960
  • Lee SH, Ko KO, Lim JW, Yoon JM, Song YH, Lee JW, Cheon EJ.
    Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis.
    Rheumatol Int. 2019 Sep 23. doi: 10.1007/s00296-019-04448-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31549188
  • Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Pediatr Rheumatol Online J. 2019 Sep 18;17(1):65. doi: 10.1186/s12969-019-0368-8.
  • Pasma H, Honkila M, Pokka T, Renko M, Salo E, Tapiainen T.
    Epidemiology of Kawasaki disease before and after universal Bacille Calmette-Guérin vaccination program was discontinued.
    Acta Paediatr. 2019 Sep 13. doi: 10.1111/apa.15012. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31520428
  • Noval Rivas M, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC, Fishbein MC, Chen S, Lehman TJ, Sato K, Shibuya A, Fasano A, Kiyono H, Abe M, Tatsumoto N, Yamashita M, Crother TR, Shimada K, Arditi M.
    Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation.
    Immunity. 2019 Sep 17;51(3):508-521.e6. doi: 10.1016/j.immuni.2019.05.021. Epub 2019 Aug 27.
  • Jin Y, Xie Q, Li N, Mo X, Liu S, Tao Y, Wang J.
    Exploration of susceptible genes associated with Henoch-Schönlein purpura by whole exome sequencing.
    Adv Clin Exp Med. 2019 Aug 19. doi: 10.17219/acem/103800.
  • van Stijn-Bringas Dimitriades D, Planken RN, Groenink M, Streekstra GJ, Kuijpers TW, Kuipers IM.
    Coronary artery assessment in Kawasaki disease with dual-source CT angiography to uncover vascular pathology.
    Eur Radiol. 2019 Aug 19. doi: 10.1007/s00330-019-06367-6.
  • Fujiwara K, Shimizu J, Tsukahara H, Shimada A.
    Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature.
    Rheumatol Int. 2019 Aug 7. doi: 10.1007/s00296-019-04404-7.
  • Savioli B, Salu BR, de Brito MV, Oliva M, de Souza A.
    Lower serum levels of transforming growth factor-β1 and disease activity in Takayasu arteritis.
    Scand J Rheumatol. 2019 Aug 21:1-2. doi: 10.1080/03009742.2019.1637454.
  • Baldwin C, Mohammad AJ, Cousins C, Carette S, Pagnoux C, Jayne D.
    Long-term outcomes of patients with Takayasu arteritis and renal artery involvement: a cohort study.
    Rheumatol Adv Pract. 2018 Aug 16;2(2):rky026. doi: 10.1093/rap/rky026.
  • Wang Y, Wang YH, Tian XP, Wang HY, Li J, Ge ZT, Yang YJ, Cai S, Zeng XF, Li JC.
    Contrast-enhanced ultrasound for evaluating arteritis activity in Takayasu arteritis patients.
    Clin Rheumatol. 2019 Aug 20. doi: 10.1007/s10067-019-04698-9.
  • Yamaji N, da Silva Lopes K, Shoda T, Ishitsuka K, Kobayashi T, Ota E, Mori R.
    TNF-α blockers for the treatment of Kawasaki disease in children.
    Cochrane Database Syst Rev. 2019 Aug 16;8:CD012448. doi: 10.1002/14651858.CD012448.pub2.
  • Abdolmanafi A, Cheriet F, Duong L, Ibrahim R, Dahdah N.
    An automatic diagnostic system of coronary artery lesions in Kawasaki Disease using IV-OCT imaging.
    J Biophotonics. 2019 Aug 18:e201900112. doi: 10.1002/jbio.201900112.
JULIO 2019
  • Burns JC.
    Cyclosporine and coronary outcomes in Kawasaki disease.
    J Pediatr. 2019 Jul;210:239-242.
  • Phuong LK, Chen KY, Burgner DP, Curtis N.
    What paediatricians need to know about the updated 2017 American Heart Association Kawasaki disease guideline.
    Arch Dis Child. 2019 Jul 3. pii: archdischild-2018-315069. doi: 10.1136/archdischild-2018-315069. [Epub ahead of print]
  • Mitani Y, Tsuda E, Kato H, Higaki T, Fujiwara M, Ogawa S et al.
    Emergence and Characterization of Acute Coronary Syndrome in Adults After Confirmed or Missed History of Kawasaki Disease in Japan: A Japanese Nationwide Survey.
    Front Pediatr. 2019 Jul 9;7:275
  • Nandi A, Pal P, Basu S.
    A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Rheumatol Int. 2019 Jul 13. doi: 10.1007/s00296-019-04375-9. [Epub ahead of print]
  • Yan J, Wang H, Gao L.
    Diagnostic Value of Serum MiR-1 in Patients with Acute Kawasaki Disease.
    Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190339.
JUNIO 2019
  • Yan J, Wang H, Gao L.
    Diagnostic Value of Serum MiR-1 in Patients with Acute Kawasaki Disease.
    Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190339.
  • Lee JJY, Alsaleem A, Chiang GPK, Limenis E, Sontichai W, Yeung RSM, Akikusa J, Laxer RM.
    Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
    Pediatr Rheumatol Online J. 2019 Jun 26;17(1):31. doi: 10.1186/s12969-019-0343-4.
  • Menikou S1, Langford PR1, Levin M1.
    Kawasaki Disease: The Role of Immune Complexes Revisited.
    Front Immunol. 2019 Jun 12;10:1156. doi: 10.3389/fimmu.2019.01156.
  • Dionne A, Burgner D, De Ferranti S, Singh-Grewal D, Newburger J, Dahdah N.
    Variation in the management of Kawasaki disease.
    Arch Dis Child. 2019 Jun 13. pii: archdischild-2019-317191. doi: 10.1136/archdischild-2019-317191.
  • Ghimire LV, Chou FS, Mahotra NB, Sharma SP.
    An update on the epidemiology, length of stay, and cost of Kawasaki disease hospitalisation in the United States.
    Cardiol Young. 2019 Jun 6:1-5. doi: 10.1017/S1047951119000982. [Epub ahead of print]
  • Son MBF, Gauvreau K, Tremoulet AH, Lo M, Baker AL, de Ferranti S, Dedeoglu F, Sundel RP, Friedman KG, Burns JC, Newburger JW.
    Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.
    J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.
ABRIL 2019
  • de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
    European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.
    Rheumatology (Oxford). 2019 Apr 1;58(4):656-671.
  • Durel CA, Hot A, Trefond L, Aumaitre O, Pugnet G, Samson M, Abad S, Belot A, Blanchard-Delaunay C, Cohen P, Cohen-Aubard F, Cottin V, Crestani B, Moreuil C, Durupt S, Garzaro M, Girszyn N, Godeau B, Hachulla E, Jamilloux Y, Jego P, Killian M, Lazaro E, Le Gallou T, Liozon E, Martin T, Papo T, Perlat A, Pillet P, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG).
    Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients.
    Rheumatology (Oxford). 2019 Mar 18. pii: kez071. doi: 10.1093/rheumatology/kez071. [Epub ahead of print]
  • Esposito S, Polinori I, Rigante D.
    The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome
    Front Pediatr. 2019 Apr 5;7:124. doi: 10.3389/fped.2019.00124. eCollection 2019. Review.
MARZO 2019
  • Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
    Rheumatology (Oxford). 2019 Mar 16. pii: kez041. doi: 10.1093/rheumatology/kez041. [Epub ahead of print]
  • Wang H, Das L, Hoh SF, Gao X, Book YX, Arkachaisri T.
    Urinalysis monitoring in children with Henoch-Schönlein purpura: Is it time to revise?
    Int J Rheum Dis. 2019 Mar 21. doi: 10.1111/1756-185X.13552. [Epub ahead of print]
  • Cakici EK, Şükür EDK, Özlü SG, Yazılıtaş F, Özdel S, Gür G, Eroğlu FK, Güngör T, Çelikkaya E, Bağlan E, Bülbül M.
    MEFV gene mutations in children with Henoch-Schönlein purpura and their correlations-do mutations matter?
    Clin Rheumatol. 2019 Mar 2. doi: 10.1007/s10067-019-04489-2. [Epub ahead of print]
  • McCrindle BW, Rowley AH.
    Improving coronary artery outcomes for children with Kawasaki disease.
    Lancet. 2019 Mar 16;393(10176):1077-1078.
  • Rodriguez-Gonzalez M, Perez-Reviriego AA, Castellano-Martinez A, Cascales-Poyatos HM
    N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease.
    Biomark Med. 2019 Mar;13(4):307-323.
  • Guleria S, Pilania RK, Jindal AK, Bhattarai D, Suri D, Singh S.
    Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience.
    Int J Rheum Dis. 2019 Mar 3. doi: 10.1111/1756-185X.13519. [Epub ahead of print]
  • Jinkawa A, Shimizu M, Nishida K, Kaneko S, Usami M, Sakumura N, Irabu H, Takakuwa M, Inoue N, Mizuta M, Ikawa Y, Fujita S, Yachie A.
    Cytokine profile of macrophage activation syndrome associated with Kawasaki disease.
    Cytokine. 2019 Mar 13;119:52-56. doi: 10.1016/j.cyto.2019.03.001. [Epub ahead of print]
  • Muruganandam M, Rolle NA, Sibbitt WL Jr, Cook GB, Emil NS, Fangtham M, Reiter KJ, Bankhurst AD.
    Characteristics of Behcet's Disease in the American Southwest.
    Semin Arthritis Rheum. 2019 Mar 9. pii: S0049-0172(18)30791-1. doi: 10.1016/j.semarthrit.2019.03.003. [Epub ahead of print]
  • Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC.
    Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study.
    Front Pediatr. 2019 Mar 29;7:121. doi: 10.3389/fped.2019.00121.
  • Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al; KAICA trial Investigators
    Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.

    Lancet. 2019 Mar 30;393(10178):1128-1137.
  • Nagelkerke SQ, Tacke CE, Breunis WB, Tanck MWT, Geissler J, Png E, et al; International Kawasaki Disease Genetics Consortium.
    Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.
    Front Immunol. 2019 Mar 21;10:185. doi: 10.3389/fimmu.2019.00185.
  • Puéchal X, Iudici M, Calich AL, Vivot A, Terrier B, Régent A, Cohen P, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L
    Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients
    Rheumatology (Oxford). 2019 Mar; 58(3):401-409
  • Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A et al for the European Vasculitis Study Group (EUVAS)
    Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
    Ann Rheum Dis 2019 Mar; 78(3):399-405
  • Durel CA, Hot A, Trefond L, Aumaitre O, Pugnet G, Samson M, et al; French Vasculitis Study Group (FVSG).
    Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients.
    Rheumatology (Oxford). 2019 Mar 18. pii: kez071. doi: 10.1093/rheumatology/kez071. [Epub ahead of print]
  • Durel CA, Hot A, Trefond L, Aumaitre O, Pugnet G, Samson M, et al; French Vasculitis Study Group (FVSG).
    Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients.
    Rheumatology (Oxford). 2019 Mar 18. pii: kez071. doi: 10.1093/rheumatology/kez071. [Epub ahead of print]
  • Kong WX, Ma FY, Fu SL, Wang W, Xie CH, Zhang YY, Gong FQ.
    Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    World J Pediatr. 2019 Feb 27. doi: 10.1007/s12519-019-00234-6. [Epub ahead of print]
  • Meyer K, Volkmann A, Hufnagel M, Schachinger E, Klau S, Horstmann J, Berner R, Fischer M, Lehner A, Haas N, Ulrich S, Jakob A.
    Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study.
    BMC Pediatr. 2019 Feb 26;19(1):66. doi: 10.1186/s12887-019-1438-2.
  • Nagata S
    Causes of Kawasaki Disease-From Past to Present.
    Front Pediatr. 2019 Feb 5;7:18. doi: 10.3389/fped.2019.00018. eCollection 2019.
  • Shi H, Qiu H, Jin Z, Li C, Yang X, Huang C, Wu R, Zhuang G, Chu M.
    Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease.
    J Investig Med. 2019 Feb 25. pii: jim-2018-000898. doi: 10.1136/jim-2018-000898. [Epub ahead of print]
  • Agrawal H, Qureshi AM.
    Cardiac Catheterization in Assessment and Treatment of Kawasaki Disease in Children and Adolescents.
    Children (Basel). 2019 Feb 21;6(2). pii: E32. doi: 10.3390/children6020032.
  • Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, Aoyama Y, Yanagawa H.
    The nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.
    Pediatr Int. 2019 Feb 20. doi: 10.1111/ped.13809. [Epub ahead of print]
  • Qiu H, Li C, He Y, Weng F, Shi H, Pan L, Guo Y, Zhang Y, Wu R, Chu M.
    Association between left ventricular ejection fraction and Kawasaki disease shock syndrome.
    Cardiol Young. 2019 Feb;29(2):178-184. doi: 10.1017/S1047951118002056.
  • Huang YH, Chen KD, Lo MH, Cai XY, Kuo HC.
    Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.
    Front Pediatr. 2019 Feb 4;7:7. doi: 10.3389/fped.2019.00007. eCollection 2019.
  • Woo HO.
    Predictive risk factors of coronary artery aneurysms in Kawasaki disease.
    Korean J Pediatr. 2019 Feb 19. doi: 10.3345/kjp.2019.00073. [Epub ahead of print]
  • Laukka D, Rahi M, Parkkola R, Vahlberg T, Rintala A, Salo E, Rinne J.
    Unlikely association between Kawasaki disease and intracranial aneurysms: a prospective cohort study.
    J Neurosurg Pediatr. 2019 Feb 15:1-4. doi: 10.3171/2018.11.PEDS18575. [Epub ahead of print]
  • Kim S, Eun LY.
    Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease.
    Korean J Pediatr. 2019 Feb 8. doi: 10.3345/kjp.2018.06905. [Epub ahead of print]
  • Tan XH, Zhang XW, Wang XY, He XQ, Fan C, Lyu TW, Tian J.
    A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients.
    Sci Rep. 2019 Feb 11;9(1):1722. doi: 10.1038/s41598-019-39330-y.
  • Peng Y, Liu X, Duan Z, Deng Y, Cai S, Wang Z, Xu K, Kang H, Jiang M, Li L, Zhou Y, Zou Z.
    Prevalence and characteristics of arthritis in Kawasaki disease: a Chinese cohort study.
    Clin Exp Med. 2019 Feb 6. doi: 10.1007/s10238-019-00547-w. [Epub ahead of print]
  • Wang YF, Lian XL, Zhong JY, Su SX, Xu YF, Xie XF, Wang ZP, Li W, Zhang L, Che D, Yu L, Huang P, Jia HL, Gu XQ.
    Serum Exosomal microRNA Let-7i-3p as Candidate Diagnostic Biomarker for Kawasaki DiseasePatients with Coronary Artery Aneurysm.
    IUBMB Life. 2019 Feb 6. doi: 10.1002/iub.2015. [Epub ahead of print]
  • Tascón AB, Malfaz FC, Sombrero HR, Fernández-Cooke E, Sánchez-Manubens J, Perez-Lescure Picarzo J; en representacion de la Sociedad Espanola de Cardiologia Pediátrica y Cardiopatias Congenitas.
    National consensus on the cardiological treatment and follow-up of Kawasaki disease
    An Pediatr (Barc). 2019 Feb;90(2):135-136. doi: 10.1016/j.anpedi.2018.12.008.
  • Jelusic M, Sestan M, Cimaz R, Ozen S.
    Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
    Pediatr Rheumatol Online J. 2019 Feb 28;17(1):10. doi: 10.1186/s12969-019-0311-z.
  • Karadağ ŞG, Tanatar A, Sönmez HE, Çakmak F, Kıyak A, Yavuz S, Çakan M, Ayaz NA.
    The clinical spectrum of Henoch-Schönlein purpura in children: a single-center study.
    Clin Rheumatol. 2019 Feb 8. doi: 10.1007/s10067-019-04460-1. [Epub ahead of print]
  • Deschamps K, Yeates KO, Fay-McClymont TB, Twilt M, Westmacott R, Dropol A, Brooks BL, Kirton A, Gowdie P, Sheikh S, Benseler SM.
    Cognitive outcomes of childhood primary CNS vasculitis.
    Neuropsychology. 2019 Feb 14. doi: 10.1037/neu0000513. [Epub ahead of print]
ENERO 2019
  • Deschamps K, Yeates KO, Fay-McClymont TB, Twilt M, Westmacott R, Dropol A, Brooks BL, Kirton A, Gowdie P, Sheikh S, Benseler SM.
    Cognitive outcomes of childhood primary CNS vasculitis.
    Neuropsychology. 2019 Feb 14. doi: 10.1037/neu0000513. [Epub ahead of print]
  • Fan L, Zhang H, Cai J, Yang L Liu B, Wei D, Yu J, Fan J, Song L, Ma W, Zhou X, Wu H, Lou Y.
    Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients.
    Arthritis Res Ther. 2019 Jan 22;21(1):31. doi: 10.1186/s13075-018-1790-x.
  • Li Y, Zheng Q, Zou L, Wu J, Guo L, Teng L, Zheng R, Jung LKL, Lu M.
    Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Pediatr Rheumatol Online J. 2019 Jan 5;17(1):1. doi: 10.1186/s12969-018-0303-4.
  • Özçelik G, Sönmez HE, Şahin S, Özağarı A, Bayram MT, Çiçek RY, Çakıcı EK, Çomak E, Barut K, Şahin N, Bakkaloğlu S, Gökçe İ, Düzova A, Bilginer Y, Açarı C, Melek E, Kılıç BD, Özdel S, Adroviç A, Kasapçopur Ö, Ünsal E, Alpay H, Orhan D, Topaloğlu R, Düşünsel R, Özen S.
    Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Pediatr Nephrol. 2019 Jan 4. doi: 10.1007/s00467-018-4162-5. [Epub ahead of print]
  • Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
    Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Clin Exp Med. 2019 Jan 8. doi: 10.1007/s10238-018-00544-5. [Epub ahead of print]
  • Aeschlimann FA, Barra L, Alsolaimani R, Benseler SM, Hebert D, Khalidi N, Laxer RM, Noone D, Pagnoux C, Twilt M, Yeung RSM.
    Presentation and Disease Course of Childhood-Onset Versus Adult-Onset Takayasu Arteritis.
    Arthritis Rheumatol. 2019 Feb;71(2):315-323. doi: 10.1002/art.40690. Epub 2018 Dec 29.
  • de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
    European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.
    Rheumatology (Oxford). 2018 Dec 7. doi: 10.1093/rheumatology/key322. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30535249
  • de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
    European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.
    Rheumatology (Oxford). 2018 Dec 7. doi: 10.1093/rheumatology/key322. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30535249
  • Rubino C1, Paci M2, Resti M1, Lionetti P2, Trapani S
    Late Relapse of Henoch-Schönlein Purpura in an Adolescent Presenting as Severe Gastroduodenitis.
    Front Pediatr. 2018 Nov 20;6:355. doi: 10.3389/fped.2018.00355.
  • Zhang F, Chen L, Shang S, Jiang K
    Atypical purpura location in a pediatric patient with Henoch-Schönlein purpura: A case report.
    Medicine (Baltimore). 2018 Nov;97(48):e13294. doi: 10.1097/MD.0000000000013294.
  • Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D
    Vascular Behçet's syndrome: an update.
    Intern Emerg Med. 2018 Nov 29. doi: 10.1007/s11739-018-1991-y. [Epub ahead of print]
  • Goswami N, Marzan K, De Oliveira E, Wagner-Lees S, Szmuszkovicz J
    Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals.
    Children (Basel). 2018 Nov 21;5(11). pii: E155. doi: 10.3390/children5110155.
  • Vervoort D, Donné M, Van Gysel D
    Pitfalls in the diagnosis and management of Kawasaki disease: An update for the pediatric dermatologist.
    Pediatr Dermatol. 2018 Nov;35(6):743-747. doi: 10.1111/pde.13620.
  • Grasa CD, Fernandez-Cooke E, Sánchez-Manubens J, Antón J, Crespo D, García M, López A, Lirola Cruz MJ, Díaz-Delgado de la Peña R, Calvo C; Spanish network for the study of Kawasaki disease, KAWA-RACE.
    Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study
    Ann Rheum Dis. 2018 Oct 3. pii: annrheumdis-2018-213891. doi: 10.1136/annrheumdis-2018-213891. [Epub ahead of print] No abstract available.
  • Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H, Barendregt AM, Menikou S, Gormley S, Berk M, Hoang LT, Tremoulet AH, Kanegaye JT, Coin LJM, Glodé MP, Hibberd M, Kuijpers TW, Hoggart CJ, Burns JC, Levin M; Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG).
    Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.
    JAMA Pediatr. 2018 Oct 1;172(10):e182293.
  • Akamine K, Punaro M.
    Biologics for childhood systemic vasculitis.
    Pediatr Nephrol. 2018 Sep 10. doi: 10.1007/s00467-018-4076-2. [Epub ahead of print]
  • Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, et al
    Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    PLoS One. 2018 Sep 4;13(9):e0202658.
  • Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J, Shimizu C, Sheets R, Tremoulet AH, Burns JC.
    Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.
    J Pediatr. 2018 Sep 26. pii: S0022-3476(18)31089-8. doi: 10.1016/j.jpeds.2018.07.090. [Epub ahead of print]
  • Kwon YC, Kim JJ, Yu JJ, Yun SW, Yoon KL, Lee KY, et al; Korean Kawasaki Disease Genetics Consortium
    Identification of the TIFAB Gene as a Susceptibility Locus for Coronary Artery Aneurysm in Patients with Kawasaki Disease.
    Pediatr Cardiol. 2018 Sep 28. doi: 10.1007/s00246-018-1992-7. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30267110
  • Che D, Pi L, Xu Y, Fu L, Zhou H, Wang Z, Huang P, Zhang L, Gu X.
    TBXA2R rs4523 G allele is associated with decreased susceptibility to Kawasaki disease.
    Cytokine. 2018 Sep 1;111:216-221. doi: 10.1016/j.cyto.2018.08.029. [Epub ahead of print]
  • Yang HF, Fan HC.
    Kawasaki disease shock syndrome and macrophage activation syndrome.
    Paediatr Int Child Health. 2018 Sep 27:1. doi: 10.1080/20469047.2018.1511028. [Epub ahead of print] 
  • Wang K, Sun X, Cao Y, Dai L, Sun F, Yu P, Dong L.
    Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study.
    Medicine (Baltimore). 2018 Sep;97(38):e12520.
  • Hwang HH, Lim IS, Choi BS, Yi DY.
    Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases.
    Medicine (Baltimore). 2018 Sep;97(36):e12217
  • Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD.
    A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
    Rheumatology (Oxford). 2018 Sep 18. doi: 10.1093/rheumatology/key288. [Epub ahead of print]
  • Ismailova DS, Abramova JV, Novikov PI, Grusha YO.
    Clinical features of different orbital manifestations of granulomatosis with polyangiitis.
    Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1751-1756
  • Zeiler SR, Qiao Y, Pardo CA, Lim M, Wasserman BA.
    Vessel Wall MRI for Targeting Biopsies of Intracranial Vasculitis.
    AJNR Am J Neuroradiol. 2018 Sep 27. doi: 10.3174/ajnr.A5801. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30262647
  • Kolkhir P, Grakhova M, Bonnekoh H, Krause K, Maurer M.
    Treatment of urticarial vasculitis: A systematic review.
    J Allergy Clin Immunol. 2018 Sep 27. pii: S0091-6749(18)31356-3. doi: 10.1016/j.jaci.2018.09.007. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30268388
  • Braun J, Baraliakos X, Fruth M.
    The role of 18F-FDG positron emission tomography for the diagnosis of vasculitides.
    Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):108-114. 
  • Watanabe T.
    Clinical features of acute kidney injury in patients with Kawasaki disease.
    World J Clin Pediatr. 2018 Aug 30;7(3):83-88. doi: 10.5409/wjcp.v7.i3.83.
  • Ozeki Y, Yamada F, Saito A, Kishimoto T, Yashiro M, Makino N, Nakamura Y.
    Epidemiologic features of Kawasaki disease distinguished by seasonal variation: an age-specific analysis.
    Ann Epidemiol. 2018 Aug 18. pii: S1047-2797(18)30008-5. doi: 10.1016/j.annepidem.2018.08.004. [Epub ahead of print]
  • Zhou Y, Wang S, Zhao J, Fang P.
    Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease.
    Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5121-5126. doi: 10.26355/eurrev_201808_15706.
  • Basha A, Rawat A, Jindal AK, Gupta A, Anand S, Garg R, Minz RW, Singh S.
    Autoantibody profile in children with Kawasaki disease on long-term follow-up: A prospective study from North India.
    Int J Rheum Dis. 2018 Aug 30. doi: 10.1111/1756-185X.13372. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30168280
  • Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Indian J Pediatr. 2018 Aug 30. doi: 10.1007/s12098-018-2765-2. [Epub ahead of print]
  • Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A.
    Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.
    Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
  • Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A.
    Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.
    Ital J Pediatr. 2018 Aug 30;44(1):103. doi: 10.1186/s13052-018-0529-2.
  • Ozen S, Batu ED.
    Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
    Front Immunol. 2018 Aug 14;9:1892. doi: 10.3389/fimmu.2018.01892.
  • Ishikawa T, Nishizawa A, Fujimoto N, Satoh T.
    Kawasaki disease-like symptoms occurring concomitantly with Hodgkin's lymphoma.
    Eur J Dermatol. 2018 Aug 27. doi: 10.1684/ejd.2018.3376. [Epub ahead of print]
  • Okabe M, Hirono K, Tamura K, Ichida F, Kanegane H.
    Reactive peripheral blood plasmacytosis in Kawasaki disease.
    Pediatr Int. 2018 Aug 20. doi: 10.1111/ped.13600. [Epub ahead of print]
  • Che D, Li J, Fu L, Pi L, Rong X, Wang Y, Xu Y, Huang P, Chu M, Gu X.
    The rs1625579 T>G polymorphism in the miRNA-13 gene confers a risk of early- onset Kawasaki disease in a southern Chinese population.
    Infect Drug Resist. 2018 Aug 3;11:1055-1060. doi: 10.2147/IDR.S174140.
  • Yang D, Kuang H, Zhou Y, Cai C, Lu T.
    Height, VKORC1 1173, and CYP2C9 Genotypes Determine Warfarin Dose for Pediatric Patients with Kawasaki Disease in Southwest China.
    Pediatr Cardiol. 2018 Aug 18. doi: 10.1007/s00246-018-1957-x. [Epub ahead of print]
  • Muthusami P, Luining W, McCrindle B, van der Geest R, Riesenkampff E, Yoo SJ, Seed M, Manlhiot C, Grosse-Wortmann L.
    Myocardial Perfusion, Fibrosis, and Contractility in Children With Kawasaki Disease.
    JACC Cardiovasc Imaging. 2018 Aug 6. pii: S1936-878X(18)30538-2. doi: 10.1016/j.jcmg.2018.06.009. [Epub ahead of print]
  • Cui J, Zhou Y, Hu H, Zhao L, Du Z, Du H.
    PGK1 as an immune target in Kawasaki disease.
    Clin Exp Immunol. 2018 Aug 16. doi: 10.1111/cei.13204. [Epub ahead of print]
  • Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA.
    Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.
    Arch Dis Child. 2018 Aug 13. pii: archdischild-2018-315087. doi: 10.1136/archdischild-2018-315087. [Epub ahead of print]
  • Cameron SA, Robinson JD, Carr MR, Patel A.
    Giant coronary artery aneurysms in an infant with Kawasaki disease: Evaluation by echocardiography and computed tomographic angiography.
    Echocardiography. 2018 Aug 12. doi: 10.1111/echo.14118. [Epub ahead of print]
  • Hule GP, Kanvinde PR, Kulkarni MA, van Leeuwen K, de Boer M, Bargir UA, Taur PD, Desai MM, Madkaikar MR4.
    p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease.
    J Clin Immunol. 2018 Aug;38(6):638-641. doi: 10.1007/s10875-018-0532-9. Epub 2018 Aug 9.
  • Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H, Barendregt AM, Menikou S, Gormley S, Berk M, Hoang LT, Tremoulet AH, Kanegaye JT, Coin LJM, Glodé MP, Hibberd M, Kuijpers TW, Hoggart CJ, Burns JC, Levin M; Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG).
    Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.
    JAMA Pediatr. 2018 Aug 6:e182293. doi: 10.1001/jamapediatrics.2018.2293. [Epub ahead of print]
  • Fernández-Cooke E, Barrios Tascón A, Antón-López J, Grasa Lozano CD, Sánchez-Manubens J, Calvo C; en representación del Grupo de trabajo para el estudio de la enfermedad de Kawasaki (KAWA-RACE).
    Previous or coincident infections with suspected Kawasaki disease. Should we change our approach?
    An Pediatr (Barc). 2018 Aug 1. pii: S1695-4033(18)30308-4. doi: 10.1016/j.anpedi.2018.06.017. [Epub ahead of print]
  • Wang F, Huang L, Tang H, Li X, Zhu X, Wang X.
    Significance of glomerular fibrinogen deposition in children with Henoch-Schönlein purpura nephritis.
    Ital J Pediatr. 2018 Aug 16;44(1):97. doi: 10.1186/s13052-018-0538-1.
  • Kisla Ekinci RM, Balcı S, Mart OO, Tumgor G, Yavuz S, Celik H, Dogruel D, Altintas DU5, Yilmaz M.
    Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children?
    Rheumatol Int. 2018 Aug 12. doi: 10.1007/s00296-018-4129-7. [Epub ahead of print]
  • Jariwala MP, Laxer RM.
    Primary Vasculitis in Childhood: GPA and MPA in Childhood.
    Front Pediatr. 2018 Aug 16;6:226. doi: 10.3389/fped.2018.00226.
  • Uehara E, Nagata C, Masuda H, Fujimori K, Kobayashi S, Kubota M, Ishiguro A.
    Risk factors of long hospital stay for IgA vasculitis: a single center study.
    Pediatr Int. 2018 Aug 21. doi: 10.1111/ped.13685. [Epub ahead of print]
  • Kaspar CDW, Sanderson K, Ozen S, Verghese PS, Lo M, Bunchman TE, Wenderfer SE, Kidd J.
    Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study.
    Int J Nephrol. 2018 Aug 5;2018:8413096. doi: 10.1155/2018/8413096.
JULIO 2018
  • Kaspar CDW, Sanderson K, Ozen S, Verghese PS, Lo M, Bunchman TE, Wenderfer SE, Kidd J.
    Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study.
    Int J Nephrol. 2018 Aug 5;2018:8413096. doi: 10.1155/2018/8413096.
  • Chbeir D, Gaschignard J, Bonnefoy R, Beyler C, Melki I, Faye A, Meinzer U
    Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions.
    Pediatr Rheumatol Online J. 2018 Jul 18;16(1):48. doi: 10.1186/s12969-018-0264-7.
  • Colomba C, La Placa S, Saporito L, Corsello G, Ciccia F, Medaglia A, Romanin B, Serra N, Di Carlo P, Cascio A.
    Intestinal Involvement in Kawasaki Disease.
    J Pediatr. 2018 Jul 17. pii: S0022-3476(18)30833-3. doi: 10.1016/j.jpeds.2018.06.034. [Epub ahead of print]
  • Okubo Y, Michihata N, Morisaki N, Sundel RP, Matsui H, Fushimi K, Yasunaga H.
    Association Between Dose of Glucocorticoids and Coronary Artery Lesions in Kawasaki Disease.
    Arthritis Care Res (Hoboken). 2018 Jul;70(7):1052-1057. doi: 10.1002/acr.23456. Epub 2018 May 22.
  • Fina A, Dubus JC, Tran A, Derelle J, Reix P, Fayon M, Couderc L, Donnou MD, Pagnier A, Blanchon S, Faure N, Mely L, Albertini M, de Blic J, Giovannini-Chami L.
    Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort.
    Pediatr Pulmonol. 2018 Jun 26. doi: 10.1002/ppul.24089. [Epub ahead of print]
JUNIO 2018
  • Clemente G, Silva CA, Sacchetti SB, Ferriani VPL, Oliveira SK, Sztajnbok F, Bica BERG, Cavalcanti A, Robazzi T, Bandeira M, Terreri MT.
    Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases.
    Rheumatol Int. 2018 Jun;38(6):1089-1094. doi: 10.1007/s00296-018-4030-4
  • Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M.
    The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.
    Autoimmun Rev. 2018 Jun 6. pii: S1568-9972(18)30135-6. doi: 10.1016/j.autrev.2018.01.024
  • Martins A, Conde M, Brito M, Gouveia C.
    Arthritis in Kawasaki disease: A poorly recognised manifestation.
    J Paediatr Child Health. 2018 Jun 26. doi: 10.1111/jpc.14102
  • Kuo HC, Guo MM, Lo MH, Hsieh KS, Huang YH.
    Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
    BMC Pediatr. 2018 Jun 22;18(1):200. doi: 10.1186/s12887-018-1180-1
  • Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH.
    N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Am J Emerg Med. 2018 Jun 8. pii: S0735-6757(18)30483-2. doi: 10.1016/j.ajem.2018.06.021
  • Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, Varela-Ortiz J, Muñoz-Ramírez M, Garrido-García M, Yamazaki-Nakashimada M.
    Kawasaki Disease Shock Syndrome; A Unique and Severe Subtype of Kawasaki Disease.
    Pediatr Int. 2018 Jun 11. doi: 10.1111/ped.13614
  • Migally K, Braunlin EA, Zhang L, Binstadt BA.
    Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.
    Pediatr Res. 2018 Jun;83(6):1136-1145. doi: 10.1038/pr.2018.44
  • Makino N, Nakamura Y, Yashiro M, Sano T, Ae R, Kosami K, Kojo T, Aoyama Y, Kotani K, Yanagawa H.
    Epidemiological observations of Kawasaki disease in Japan, 2013-2014.
    Pediatr Int. 2018 Jun;60(6):581-587. doi: 10.1111/ped.13544
  • Kawai R, Nomura O, Tomobe Y, Morikawa Y, Miyata K, Sakakibara H, Miura M.
    Retrospective observational study indicates that the paediatric assessment triangle may suggest the severity of Kawasaki disease.
    Acta Paediatr. 2018 Jun;107(6):1049-1054. doi: 10.1111/apa.14249
  • Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
    The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
    J Microbiol Immunol Infect. 2018 Jun;51(3):321-331. doi: 10.1016/j.jmii.2017.08.012
MAYO 2018
  • Bijnens J, Missiaen L, Bultynck G, Parys JB.
    A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease.
    Cell Calcium. 2018 May;71:95-103. doi: 10.1016/j.ceca.2018.01.002. Epub 2018 Feb 3.
  • Zhang XY, Yang TT, Hu XF, Wen Y, Fang F, Lu HL.
    Circulating adipokines are associated with Kawasaki disease.
    Pediatr Rheumatol Online J. 2018 May 8;16(1):33. doi: 10.1186/s12969-018-0243-z.
  • Choi JE, Kwak Y, Huh JW, Yoo ES, Ryu KH, Sohn S, Hong YM.
    Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.
    Korean J Pediatr. 2018 May;61(5):167-173. doi: 10.3345/kjp.2018.61.5.167. Epub 2018 May 28.
  • Seo YM, Kang HM, Lee SC, Yu JW, Kil HR, Rhim JW, Han JW, Lee KY.
    Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment.
    Korean J Pediatr. 2018 May;61(5):160-166. doi: 10.3345/kjp.2018.61.5.160. Epub 2018 May 28.
  • Riancho-Zarrabeitia L, Rasilla DF, Royé D, Fdez-Arroyabe P, Santurtún A.
    Kawasaki disease in Spanish paediatric population and synoptic weather types: an observational study.
    Rheumatol Int. 2018 May 30. doi: 10.1007/s00296-018-4066-5. [Epub ahead of print]
  • Grotenhuis HB, Aeschlimann FA, Hui W, Slorach C, Yeung RSM, Benseler SM, Bradley TJ, Grosse-Wortmann L.
    Increased Arterial Stiffness in a Cohort of Pediatric Takayasu Arteritis Patients in Toronto Adversely Affects Left Ventricular Mechanics.
    J Clin Rheumatol. 2018 May 19. doi: 10.1097/RHU.0000000000000824. [Epub ahead of print]
ABRIL 2018
  • Wei-Te Lei, Po-Li Tsai, Szu-Hung Chu, Yu-Hsuan Kao, Chien-Yu Lin, Li-Ching Fang, Shyh-Dar Shyur,Yu-Wen Lin, and Shu-I Wu
    Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database
    Pediatr Rheumatol Online J. 2018; 16: 25. Published online 2018 Apr 16. doi:  10.1186/s12969-018-02478
  • Wang JC, Leader BA, Crane RA, Koch BL, Smith MM, Ishman SL.
    Granulomatosis with polyangiitis presenting as facial nerve palsy in a teenager.
    Int J Pediatr Otorhinolaryngol. 2018 Apr;107:160-163. doi: 10.1016/j.ijporl.2018.02.009. Epub 2018 Feb 7.
  • Mangodt TC, Joos R, Siozopoulou V, Cortoos PJ, Baeten H, Docx M, van den Akker M.
    Perinuclear antineutrophil cytoplasmic antibody-positive vasculitis, oligoarthritis, tendinitis, and myositis associated with isotretinoin in a 15-year-old boy: Case report and review of literature.
    Pediatr Dermatol. 2018 Apr 11. doi: 10.1111/pde.13445. [Epub ahead of print]
  • Nanthapisal S, Eleftheriou D, Gilmour K, Leone V, Ramnath R, Omoyinmi E, Hong Y, Klein N, Brogan PA.
    Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.
    Front Immunol. 2018 Apr 11;9:735. doi: 10.3389/fimmu.2018.00735. eCollection 2018.
  • Clemente G, Silva CA, Sacchetti SB, Ferriani VPL, Oliveira SK, Sztajnbok F, Bica BERG, Cavalcanti A, Robazzi T, Bandeira M, Terreri MT.
    Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases.
    Rheumatol Int. 2018 Apr 23. doi: 10.1007/s00296-018-4030-4. [Epub ahead of print]
  • González-Gay MA, López-Mejías R, Pina T, Blanco R, Castañeda S.
    IgA Vasculitis: Genetics and Clinical and Therapeutic Management.
    Curr Rheumatol Rep. 2018 Apr 2;20(5):24. doi: 10.1007/s11926-018-0735-3.
  • Bijnens J, Missiaen L, Bultynck G, Parys JB.
    A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease.
    Cell Calcium. 2018 May;71:95-103. doi: 10.1016/j.ceca.2018.01.002. Epub 2018 Feb 3.
  • Şanlidag B, Balkan C, Bahçeciler N.
    A case report: incomplete Kawasaki disease in a hypogammaglobulinémie child.
    Arch Argent Pediatr. 2018 Apr 1;116(2):e322-e324. doi: 10.5546/aap.2018.eng.e322.
  • Huang YH, Kuo HC, Li SC, Cai XY, Liu SF, Kuo HC.
    HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
    J Mol Cell Cardiol. 2018 Apr;117:82-87. doi: 10.1016/j.yjmcc.2018.02.017. Epub 2018 Mar 2.
  • Guillaume MP, Reumaux H, Dubos F.
    Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm.
    Cardiol Young. 2018 May;28(5):739-742. doi: 10.1017/S1047951117002864. Epub 2018 Feb 19.
MARZO 2018
  • Clark DE, Denby KJ, Kaufman LM, Fill MA, Piya B, Krishnaswami S, Fonnesbeck C, Halasa N
    Predictors of Intravenous Immunoglobulin Non-Response and Racial Disparities in Kawasaki Disease.
    Pediatr Infect Dis J. 2018 Mar 19. doi: 10.1097/INF.0000000000002019. [Epub ahead of print]
  • Migally K, Braunlin EA, Zhang L, Binstadt BA.
    Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in kawasaki disease.
    Pediatr Res. 2018 Mar 19. doi: 10.1038/pr.2018.44. [Epub ahead of print]
  • Zhang DF, Hao GX, Li CZ, Yang YJ, Liu FJ, Liu L, Yuan XY, Li RH, Dong L, Dong Q, Jacqz-Aigrain E, Zhao W.
    Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study.
    Arch Dis Child. 2018 Mar 13. pii: archdischild-2017-313788. doi: 10.1136/archdischild-2017-313788. [Epub ahead of print]
  • Frantellizzi V, Morreale M, Pontico M, Francia A, Drudi FM, Farcomeni A, Liberatore M
    99mTc-HMPAO SPECT cerebral en la monitorización de la terapia de vasculitis
    Rev Esp Med Nucl Imagen Mol. 2018 Mar 28. pii: S2253-654X(17)30127-0. doi: 10.1016/j.remn.2017.10.009. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/29605630
  • Berti A, Matteson EL, Crowson CS, Specks U, Cornec D.
    Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study.
    Mayo Clin Proc. 2018 Mar 24. pii: S0025-6196(18)30109-5. doi: 10.1016/j.mayocp.2018.02.010. [Epub ahead of print]
  • Prendecki M, Martin L, Tanna A, Antonelou M, Pusey CD.
    Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170661. doi: 10.3899/jrheum.170661. [Epub ahead of print]
  • Onuora S.
    Vasculitis: New insights into risk factors for GPA.
    Nat Rev Rheumatol. 2018 Mar 15. doi: 10.1038/nrrheum.2018.44. [Epub ahead of print]
  • Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J. 2018 Feb 15. doi: 10.1097/INF.0000000000001951.
    Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children with Kawasaki Disease Presenting with Coronary Artery Lesions: Is Dual Therapy More Effective?
ENERO 2018
  • Kawai R, Nomura O, Tomobe Y, Morikawa Y, Miyata K, Sakakibara H, Miura M.
    Retrospective observational study indicates that the Pediatric Assessment Triangle may suggest the severity of Kawasaki disease.
    Acta Paediatr. 2018 Jan 31. doi: 10.1111/apa.14249. [Epub ahead of print]
  • Kawai R, Nomura O, Tomobe Y, Morikawa Y, Miyata K, Sakakibara H, Miura M.
    Retrospective observational study indicates that the Pediatric Assessment Triangle may suggest the severity of Kawasaki disease.
    Acta Paediatr. 2018 Jan 31. doi: 10.1111/apa.14249. [Epub ahead of print]
  • Li J, Li H, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X.
    Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis.
    J Rheumatol. 2017 Dec;44(12):1867-1874.
  • Kamiyama H, Ayusawa M, Ogawa S, Saji T, Hamaoka K.
    Transition in Patients With Coronary Artery Lesions After Kawasaki Disease.
    Pediatr Int. 2017 Dec 31. doi: 10.1111/ped.13500. [Epub ahead of print]
  • Huang X, Huang P, Zhang L, Xie X, Xia S, Gong F, Yuan J, Jin L.
    Is aspirin necessary in the acute phase of Kawasaki disease?
    J Paediatr Child Health. 2017 Dec 22. doi: 10.1111/jpc.13816. [Epub ahead of print]
  • Dhanrajani A, Chan M, Pau S, Ellsworth J, Petty R, Guzman J.
    Aspirin dose in Kawasaki disease - the ongoing battle.
    Arthritis Care Res (Hoboken). 2017 Dec 29. doi: 10.1002/acr.23504. [Epub ahead of print]
  • Crnogorac M, Horvatic I, Kacinari P, Ljubanovic DG, Galesic K.
    Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.
    J Nephrol. 2017 Oct 13. doi: 10.1007/s40620-017-0445-3. [Epub ahead of print]
  • Liu Y, Zhu J, Lai JM, Sun XF, Hou J, Zhou ZX, Yuan XY.
    Reports of three cases with the initial presentation of mesenteric vasculitis in children with system lupus erythematous.
    Clin Rheumatol. 2017 Oct 10. doi: 10.1007/s10067-017-3841-0. [Epub ahead of print]
  • Hennies I, Gimpel C, Gellermann J, Möller K, Mayer B, Dittrich K, Büscher AK, Hansen M, Aulbert W, Wühl E, Nissel R, Schalk G, Weber LT, Pohl M, Wygoda S, Beetz R, Klaus G, Fehrenbach H, König S, Staude H, Beringer O, Bald M, Walden U, von Schnakenburg C, Bertram G, Wallot M, Häffner K, Wiech T, Hoyer PF, Pohl M; German Society of Pediatric Nephrology.
    Presentation of pediatric Henoch-Schönlein purpura nephritis changes with age and renal histology depends on biopsy timing.
    Pediatr Nephrol. 2017 Oct 5. doi: 10.1007/s00467-017-3794-1. [Epub ahead of print]
  • Ohtomo R, Suzuki Y, Maeda N, Kawakami S, Yamada M, Iwata A, Nakase H.
    Successful treatment of recurrent primary CNS vasculitis with etanercept.
    J Neurol Sci. 2017 Oct 15;381:200-202. doi: 10.1016/j.jns.2017.08.3257. Epub 2017.
  • Portman MA, Shrestha S.
    One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.
    Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001917. doi: 10.1161/CIRCGENETICS.117.001917.
  • Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    PLoS One. 2017 Oct 10;12(10):e0185880. doi: 10.1371/journal.pone.0185880.
  • Tremoulet AH.
    Adjunctive therapies in Kawasaki disease
    Int J Rheum Dis. 2017 Oct 27. doi: 10.1111/1756-185X.13208. [Epub ahead of print]
  • Okubo Y, Michihata N, Morisaki N, Sundel RP, Matsui H, Fushimi K, Yasunaga H.
    Association between dose of glucocorticoids and coronary artery lesions in Kawasaki disease
    Arthritis Care Res (Hoboken). 2017 Oct 26. doi: 10.1002/acr.23456. [Epub ahead of print]
  • Lee KH, Park JH, Kim DH, Hwang J, Lee G, Hyun JS, Heo ST, Choi JH, Kim M, Kim M, Kim SI, Eisenhut M, Kronbichler A, Shin JI.
    Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP)
    Med Hypotheses. 2017 Oct;108:42-45. doi: 10.1016/j.mehy.2017.07.018. Epub 2017 Jul 17.
  • Heineke MH, Ballering AV, Jamin A, Mkaddem SB, Monteiro RC, Van Egmond M.
    New Insights in the Pathogenesis of Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura).
    Autoimmun Rev. 2017 Oct 13. pii: S1568-9972(17)30259-8. doi: 10.1016/j.autrev.2017.10.009. [Epub ahead of print] Review.
  • Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, Hellmich B, Jayne D, Jennette JC, Kallenberg CGM, Moiseev S, Novikov P, Radice A, Savige JA, Sinico RA, Specks U, van Paassen P, Zhao MH, Rasmussen N, Damoiseaux J, Csernok E.
    Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.
    Nat Rev Rheumatol. 2017 Sep 14. doi: 10.1038/nrrheum.2017.140. [Epub ahead of print]
  • Frumholtz L, Laurent-Roussel S, Aumaître O, Maurier F, Le Guenno G, Carlotti A, Dallot A, Kemeny JL, Antunes L, Froment N, Fraitag S, London J, Berezne A, Terris B, Le Jeunne C, Mouthon L, Aractingi S, Guillevin L, Dupin N, Terrier B; French Vasculitis Study Group.
    Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides
    Autoimmun Rev. 2017 Sep 14. pii: S1568-9972(17)30233-1. doi: 10.1016/j.autrev.2017.09.009. [Epub ahead of print]
  • Berti A, Cornec D, Crowson CS, Specks U, Matteson EL.
    The epidemiology of ANCA associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study.
    Arthritis Rheumatol. 2017 Sep 7. doi: 10.1002/art.40313. [Epub ahead of print]
  • Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
    The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
    J Microbiol Immunol Infect. 2017 Sep 6. pii: S1684-1182(17)30195-0. doi: 10.1016/j.jmii.2017.08.012. [Epub ahead of print]
  • Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T.
    A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.
    Arthritis Res Ther. 2017 Sep 6;19(1):197. doi: 10.1186/s13075-017-1408-8.
  • Coit P, Direskeneli H, Sawalha AH.
    An update on the role of epigenetics in systemic vasculitis.
    Curr Opin Rheumatol. 2017 Sep 27. doi: 10.1097/BOR.0000000000000451. [Epub ahead of print]
  • Lopalco G, Fabiani C, Venerito V, Lapadula G, Iannone F, Cantarini L.
    Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.
    Clin Exp Rheumatol. 2017 Sep 7. [Epub ahead of print]
  • Singh S, Gupta A, Jindal AK, Gupta A, Suri D, Rawat A, Vaidya PC, Singh M.
    Pulmonary presentation of Kawasaki disease-A diagnostic challenge.
    Pediatr Pulmonol. 2017 Sep 26. doi: 10.1002/ppul.23885. [Epub ahead of print]
  • Kim JJ, Yun SW, Yu JJ, Yoon KL, Lee KY, Kil HR, Kim GB, Han MK, Song MS, Lee HD, Ha KS, Sohn S, Johnson TA, Takahashi A, Kubo M, Tsunoda T, Ito K, Onouchi Y, Hong YM, Jang GY, Lee JK; Korean Kawasaki Disease Genetics Consortium.
    A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
    J Hum Genet. 2017 Aug 31. doi: 10.1038/jhg.2017.87. [Epub ahead of print]
  • Lava SAG, Milani GP, Fossali EF, Simonetti GD, Agostoni C, Bianchetti MG.
    Cutaneous Manifestations of Small-Vessel Leukocytoclastic Vasculitides in Childhood.
    Clin Rev Allergy Immunol. 2017 Aug 24. doi: 10.1007/s12016-017-8626-3. [Epub ahead of print]
  • Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.
    Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
    Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.
JULIO 2017
  • Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.
    Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
    Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.
  • Piram M, Maldini C, Biscardi S, De Suremain N, Orzechowski C, Georget E, Regnard D, Koné-Paut I, Mahr A.
    Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study.
    Rheumatology (Oxford). 2017 Apr 24. doi: 10.1093/rheumatology/kex158. [Epub ahead of print]
JUNIO 2017
  • van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C.
    Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
    Ann Rheum Dis. 2017 Jun;76(6):1064-1069
  • Alibaz-Oner F, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Salvarani C, Matteson EL, Warrington KJ.
    Clinical Spectrum of Medium-Sized Vessel Vasculitis.
    Arthritis Care Res (Hoboken). 2017 Jun;69(6):884-891
  • Álvarez EP, Rey F, Peña SC, Rubio A, Calvo C, Collado P.
    Has joint involvement lessened in Kawasaki disease?
    Reumatol Clin. 2017 May - Jun;13(3):145-149.
  • Erden A, Batu ED, Sönmez HE, Sarı A, Armagan B, Arıcı ZS, Bilgin E, Kalyoncu U, Karadağ Ö, Bilginer Y, Ertenli AI, Özen S.
    Comparing polyarteritis nodosa in children and adults: a single center study.
    Int J Rheum Dis. 2017 Jun 19 doi: 10.1111/1756-185X.13120.
  • Ozen S, Acar-Ozen NP.
    Recent advances in childhood vasculitis.
    Curr Opin Rheumatol. 2017 Jun 2 doi: 10.1097/BOR.0000000000000424.
MAYO 2017
  • Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielson SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; for ARChiVe Investigators Network within the PedVas Initiative.
    Early Outcomes in Children with Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV).
    Arthritis Rheumatol. 2017 Mar 28. doi: 10.1002/art.40112. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28371513
  • Li J, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X
    The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years.
    Arthritis Res Ther. 2017 May 25;19(1):107. doi: 10.1186/s13075-017-1307-z.
  • Gudbrandsson B, Molberg Ø, Palm Ø.
    TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
    Arthritis Res Ther. 2017 May 18;19(1):99. doi: 10.1186/s13075-017-1316-y.
  • Ozen S, Acar-Ozen NP.
    Recent advances in childhood vasculitis.
    Curr Opin Rheumatol. 2017 Jun 2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28582318
  • Dikkes A, Aschwanden M, Imfeld S, Glatz K, Messerli J, Staub D, Daikeler T.
    Takayasu arteritis: active or not, that's the question.
    Rheumatology (Oxford). 2017 Jun 7. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28595278
ABRIL 2017
  • Valenti S, Gallizzi R, De Vivo D, Romano C.
    Intestinal Behçet and Crohn's disease: two sides of the same coin
    Pediatr Rheumatol Online J. 2017 Apr 20;15(1):33. doi: 10.1186/s12969-017-0162-4. Review.
  • Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RS, Toth MB, Shenoi S, Ristic G, Nielson SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; for ARChiVe Investigators Network within the PedVas Initiative.
    Early Outcomes in Children with Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
    Arthritis Rheumatol. 2017 Mar 28. doi: 10.1002/art.40112. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28371513
MARZO 2017
  • Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S et al for the Vasculitis Clinical Research Consortium
    A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis
    Arthritis Rheumatol 2017 Apr;69(4):846-53  DOI: 10.1002/art.40037.
  • Vijayvergiya R, Bhattad S, Varma S, Singhal M, Gordon J, Singh S.
    Presentation of missed childhood Kawasaki disease in adults: Experience from a tertiary care center in north India
    Int J Rheum Dis 5 Apr 2017 DOI: 10.1111/1756-185X.13073 [Epub ahead of print] http://onlinelibrary.wiley.com/doi/10.1111/1756-185X.13073/abstract
  • Sánchez-Manubens J, Gelman A, Franch N, Teodoro S, Palacios JR, Rudi N, Rivera J, Antón J.
    A child with resistant Kawasaki disease successfully treated with anakinra: a case report.
    BMC Pediatr. 2017 Apr 8;17(1):102. doi: 10.1186/s12887-017-0852-6.
  • McCrindle BW, Selamet Tierney ES.
    Acute Treatment for Kawasaki Disease: Challenges for Current and Future Therapies.
    J Pediatr. 2017 Feb 20. pii: S0022-3476(17)30182-8. doi: 10.1016/j.jpeds.2017.01.072. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28233548
  • Ramelli V, Lava SA, Simonetti GD, Bianchetti MG, Ramelli GP, Milani GP.
    Blistering eruptions in childhood Henoch-Schönlein syndrome: systematic review of the literature.
    Eur J Pediatr. 2017 Feb 4. doi: 10.1007/s00431-017-2858-3. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28161822
  • Delbet JD, Hogan J, Aoun B, Stoica I, Salomon R, Decramer S, Brocheriou I, Deschênes G, Ulinski T.
    Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
    Pediatr Nephrol. 2017 Feb 15. doi: 10.1007/s00467-017-3604-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28204946
  • Dos Santos D, Langer FW, Dos Santos T, Rafael Tronco Alves G, Feiten M, Teixeira de Paula Neto W.
    Posterior reversible encephalopathy syndrome as a complication of Henoch-Schönlein purpura in a seven-year-old girl.
    Scott Med J. 2017 Feb;62(1):34-37. doi: 10.1177/0036933017690467. Epub 2017 Feb 2.
ENERO 2017
  • Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M.
    Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
    Arthritis Rheumatol. 2017 Feb;69(2):268-276. doi: 10.1002/art.39975.
  • Amarilyo G, Koren Y, Brik Simon D, Bar-Meir M, Bahat H, Helou MH, Mendelson A, Hezkelo N, Chodick G, Berkun Y, Eisenstein E, Butbul Aviel Y, Barkai G, Bolkier Y, Padeh S, Brik R, Hashkes PJ, Harel L, Uziel Y.
    High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
    Clin Exp Rheumatol. 2017 Jan 5. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28079513
  • Butbul Aviel Y, Dafna L, Pilar G, Brik R.
    Endothelial function in children with a history of henoch schonlein purpura.
    Pediatr Rheumatol Online J. 2017 Jan 14;15(1):3. doi: 10.1186/s12969-016-0135-z.
  • Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP.
    National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
    Clin Rheumatol. 2016 Dec 16
  • van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C.
    Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
    Ann Rheum Dis. 2016 Nov 29.
  • Gudbrandsson B, Wallenius M, Garen T, Henriksen T, Molberg Ø, Palm Ø.
    Takayasu arteritis and pregnancy; - a population based study on outcome and mother-child related concerns.
    Arthritis Care Res (Hoboken). 2016 Nov 3
  • James KE, Xiao R, Merkel PA, Weiss PF.
    Variation in treatment of children hospitalized with antineutrophil cytoplasmic antibody-associated vasculitis in the United States.
    Arthritis Care Res (Hoboken). 2016 Nov 3.
  • Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative.
    Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study
    Arthritis Rheumatol. 2016 Oct;68(10):2514-26.
  • Giménez-Roca C, Iglesias E, Vicente MA, Bou R, Calzada-Hernández J, Prat C, García M, Antón J.
    Pediatric cryoglobulinemic vasculitis successfully managed with rituximab.
    Dermatol Ther. 2016 Oct 28
  • Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA.
    Paediatric Behçet's disease: a UK tertiary centre experience
    Clin Rheumatol. 2016 Oct;35(10):2509-16
  • Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M.
    Found in Translation: International initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease
    Arthritis Rheumatol. 2016 Oct 28.
JULIO 2016
  • Nakagomi D, Jayne D.
    Outcome assessment in Takayasu arteritis.
    Rheumatology (Oxford). 2016 Jul;55(7):1159-71. doi: 10.1093/rheumatology/kev366. Epub 2015 Oct 15.
  • Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA.
    Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK.
    Rheumatology (Oxford). 2016 Jul;55(7):1263-72. doi: 10.1093/rheumatology/kew029. Epub 2016 Mar 29.
  • Calvo-Río V, Hernández JL, Ortiz-Sanjuán F, Loricera J, Palmou-Fontana N, González-Vela MC, González-Lamuño D, González-López MA, Armesto S, Blanco R, González-Gay MA.
    Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center.
    Medicine (Baltimore). 2016 Jul;95(28):e4217. doi: 10.1097/MD.0000000000004217.
JUNIO 2016
  • Fotis L, Tuttle PV 4th, Baszis KW, Pepmueller PH, Moore TL, White AJ.
    Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases.
    Pediatr Rheumatol Online J. 2016 Jun 23;14(1):37. doi: 10.1186/s12969-016-0100-x
  • Lopalco G, Rigante D, Venerito V, Emmi G, Anelli MG, Lapadula G, Iannone F, Cantarini L.
    Management of Small Vessel Vasculitides.
    Curr Rheumatol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11926-016-0580-1. Review.
  • Loricera J, Blanco R, Hernández JL, Castañeda S, Humbría A, Ortego N, Bravo B, Freire M, Melchor S, Mínguez M, Salvatierra J, González-Vela C, Calvo-Río V, Santos-Gómez M, Pina T, González-Gay MA.
    Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
    Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):44-53
MAYO 2016
ABRIL 2016
  • Lopalco G, Rigante D, Venerito V, Emmi G, Anelli MG, Lapadula G, Iannone F, Cantarini L.
    Management of Small Vessel Vasculitides.
    Curr Rheumatol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11926-016-0580-1. Review.
  • Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins G, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik M, Lawson E, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater H, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas initiative.
    Comparing presenting clinical features of 48 children with microscopic polyangiitis (MPA) against 183 having granulomatosis with polyangiitis (GPA). An ARChiVe study.
    Arthritis Rheumatol. 2016 Apr 25. doi: 10.1002/art.39729
  • Mauro A, Fabi M, Da Frè M, Guastaroba P, Corinaldesi E, Calabri GB, Giani T, Simonini G, Rusconi F, Cimaz R.
    Kawasaki disease: an epidemiological study in central Italy.
    Pediatr Rheumatol Online J. 2016 Apr 12;14(1):22. doi: 10.1186/s12969-016-0084-6.
  • Eleftheriou D, Brogan PA.
    Therapeutic advances in the treatment of vasculitis.
    Pediatr Rheumatol Online J. 2016 Apr 26;14(1):26. doi: 10.1186/s12969-016-0082-8. Review.
MARZO 2016
  • Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J; and the Kawasaki Disease in Catalonia Working Group.
    Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain.
    Clin Exp Rheumatol. 2016 Mar 3. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26939753
  • Han SB, Lee SY, Jeong DC, Kang JH.
    Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?
    Ann Rheum Dis. 2016 Mar 10. pii: annrheumdis-2016-209395. doi: 10.1136/annrheumdis-2016-209395.
  • Aggarwal V, Etinger V, Orjuela AF.
    Sensorineural hearing loss in Kawasaki disease.
    Ann Pediatr Cardiol. 2016 Jan-Apr;9(1):87-9. doi: 10.4103/0974-2069.171396.
  • Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA.
    Paediatric Behçet's disease: a UK tertiary centre experience.
    Clin Rheumatol. 2016 Feb 1. [Epub ahead of print]
  • Hoyos-Bachiloglu R, García Á, Morales PS, Cerda J, Talesnik E, Borzutzky A.
    Geographic distribution of Kawasaki disease throughout Chile
    Rev Chilena Infectol. 2016 Feb;33(1):12-8. doi: 10.4067/S0716-10182016000100002.
  • Baek JY, Song MS.
    Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Korean J Pediatr. 2016 Feb;59(2):80-90. doi: 10.3345/kjp.2016.59.2.80. Epub 2016 Feb 29.
  • Kim JO, Kim YH, Hyun MC.
    Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy.
    Korean J Pediatr. 2016 Feb;59(2):54-8. doi: 10.3345/kjp.2016.59.2.54. Epub 2016 Feb 29.
  • Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S.
    Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.
    Int J Mol Sci. 2016 Feb 24;17(3). pii: E278. doi: 10.3390/ijms17030278.
  • Kuramitsu S, Hiromasa T, Jinnouchi H, Domei T, Shirai S, Ando K.
    Usefulness of rotational atherectomy with optical frequency domain imaging guidance for severe calcified coronary lesions after Kawasaki disease.
    Cardiovasc Interv Ther. 2016 Feb 26. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26920894
  • Hall GC, Tulloh LE, Tulloh RM.
    Kawasaki disease incidence in children and adolescents an observational study in primary care.
    Br J Gen Pract. 2016 Feb 23. pii: bjgpapr-2016-66-645-hall-fl-p. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26906631
  • Singh S, Kawasaki T.
    Kawasaki Disease in India, Lessons Learnt Over the Last 20 Years.
    Indian Pediatr. 2016 Feb 8;53(2):119-24.
  • Tang Y, Gao X, Shen J, Sun L, Yan W.
    Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience.
    J Trop Pediatr. 2016 Feb 15. pii: fmv077. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26884440
  • Chen KY, Curtis N, Dahdah N, Kowalski R, Cheung M, Burgner DP.
    Kawasaki Disease and Cardiovascular Risk: A Comprehensive Review of Subclinical Vascular Changes in the Longer Term.
    Acta Paediatr. 2016 Feb 16. doi: 10.1111/apa.13367. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26880292
  • Li Z, Tan Z, Hao S, Jin B, Deng X, Hu G, Liu X, Zhang J, Jin H, Huang M, Kanegaye JT, Tremoulet AH, Burns JC, Wu J, Cohen HJ, Ling XB; Emergency Medicine Kawasaki Disease Research Group.
    Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses.
    PLoS One. 2016 Feb 9;11(2):e0146733. doi: 10.1371/journal.pone.0146733. eCollection 2016.
  • Kitamura S.
    Pediatric Coronary Artery Revascularization Surgery: Development and Effects on Survival, Cardiac Events and Graft Patency for Children With Kawasaki Disease Coronary Involvements.
    Iran J Pediatr. 2016 Feb;26(1):e3875. doi: 10.5812/ijp.3875. Epub 2016 Jan 30.
  • Sahin S, Adrovic A, Barut K, Kasapcopur O.
    Childhood-onset eosinophilic granulomatosis with polyangiitis: a rare childhood vasculitis mimicking anthrax and eosinophilic leukaemia.
    BMJ Case Rep. 2016 Feb 17;2016. pii: bcr2015213856. doi: 10.1136/bcr-2015-213856.
  • Mathew AJ, Goel R, Kumar S, Danda D.
    Childhood-onset Takayasu arteritis: an update.
    Int J Rheum Dis. 2016 Feb;19(2):116-26. doi: 10.1111/1756-185X.12718. Epub 2015 Nov 20.
  • Singh-Grewal D, Durkan AM.
    Pediatric Vasculitis.
    Indian J Pediatr. 2016 Feb;83(2):156-62. doi: 10.1007/s12098-015-1876-2. Epub 2015 Sep 14.
  • Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.

    PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603
  • Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW.
    Cardiovascular imaging in children and adults following Kawasaki disease.
    Insights Imaging. 2015 Dec;6(6):697-705. doi: 10.1007/s13244-015-0422-0.
  • Agarwal S, Mulkutkar S, Suri D, Singh S, Gupta A.
    Retinal Vasculitis in Kawasaki Disease.
    Indian J Pediatr. 2015 Dec;82(12):1183-4. doi: 10.1007/s12098-015-1763-x
  • Surjit Singh, Pandiarajan Vignesh, David Burgner
    The epidemiology of Kawasaki disease: a global update

    Arch Dis Child 2015;100:1084-1088 doi:10.1136/archdischild-2014-307536
  • Mieko Yamagata, Kei Ikeda, Kenji Tsushima, Ken Iesato, Mitsuhiro Abe, Takashi Ito, Daisuke Kashiwakuma, Shin-ichiro Kagami, Itsuo Iwamoto, Daiki Nakagomi, Takao Sugiyama, Yuichiro Maruyama, Shunsuke Furuta, David Jayne, Takashi Uno, Koichiro Tatsumi and Hiroshi Nakajima
    Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis – a multicenter, longitudinal, retrospective study of 150 hospital-based consecutive Japanese patients

    Arthritis & Rheumatology DOI: 10.1002/art.39475
  • Takuto Takahashi, Hiroshi Sakakibara, Yoshihiko Morikawa, Masaru Miura
    Development of coronary artery lesions in indolent kawasaki disease following initial spontaneous defervescence: a retrospective cohort study

    Pediatric Rheumatology 2015, 13:44 (4 November 2015)
  • Dietz SM, Tacke CE, Gort J, Kuipers IM, de Groot E, Wiegman A, Hutten BA, Kuijpers TW.
    Carotid Intima-Media Thickness in Patients With a History of Kawasaki Disease.
    Circ J. 2015 Oct 6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26439324
  • Hong Y, Eleftheriou D, Klein NJ, Brogan PA.
    Impaired function of endothelial progenitor cells in children with primary systemic vasculitis.
    Arthritis Res Ther. 2015 Oct 16;17(1):292. doi: 10.1186/s13075-015-0810-3.
  • Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, Marek J, Klein N, Brogan PA.
    Cardiovascular status after Kawasaki disease in the UK
    Heart. 2015 Oct 15;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734. Epub 2015 Aug 27
  • Yesilkaya S, Acikel C, Fidanci BE, Polat A, Sozeri B, Ayaz NA, Makay BB, Simsek D, Akinci N, Özçelik G, Kavukçu S, Emre S, Donmez O, Delibas A, Yüksel S, Berdeli A, Poyrazoglu H, Saldir M, Fidanci K, Çakar N, Peru H, Bakkaloglu S, Tabel Y, Sari O, Aydogan U, Ozenc S, Basbozkurt G, Unsal E, Kasapcopur O, Gok F, Ozen S, Demirkaya E.
    Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children
    Clin Exp Rheumatol. 2015 Sep 22. [Epub ahead of print]
  • Mohammad AJ, Smith RM, Chow YW, Chaudhry AN, Jayne DRW.
    Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience
    J Rheumatol October 2015 42(10):1906-13; doi:10.3899/jrheum.141344
  • Felicetti P, Trotta F, Bonetto C, Santuccio C, Pernus YB, Burgner D, Chandler R, Girolomoni G, Hadden RD, Kochar S, Kukucu M, Monaco G, Ozen S, Pahud B, Phuong L, Bachtiar NS, Teeba A, Top K, Varricchio F, Wise RP, Zanoni G, Živkovic S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group.
    Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
    Vaccine. 2015 Sep 18. pii: S0264-410X(15)01293-1. doi: 10.1016/j.vaccine.2015.09.027. [Epub ahead of print]
  • Mori Y, Katayama H, Kishi K, Ozaki N, Shimizu T, Tamai H.
    Persistent high fever for more than 10 days during acute phase is a risk factor for endothelial dysfunction in children with a history of Kawasaki disease.
    J Cardiol. 2015 Sep 14. pii: S0914-5087(15)00265-8. doi: 10.1016/j.jjcc.2015.08.008.  [Epub ahead of print]
  • Turnier JL, Anderson MS, Heizer HR, Jone PN, Glodé MP, Dominguez SR.
    Concurrent Respiratory Viruses and Kawasaki Disease.
    Pediatrics. 2015 Aug 24. pii: peds.2015-0950. EPUB ahead of print]
  • Tremoulet AH, Dutkowski J, Sato Y, Kanegaye JT, Ling XB, Burns JC.
    Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.
    Pediatr Res. 2015 Aug 3. doi:10.1038/pr.2015.137. EPUB ahead of print]
JULIO 2015
  • Soliman M, Laxer R, Manson D, Yeung R, Doria AS.
    Imaging of systemic vasculitis in childhood.
    Pediatr Radiol. 2015 Jul;45(8):1110-25. doi: 10.1007/s00247-015-3339-3. Epub 2015 Jul 22.
JUNIO 2015
  • Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS).
    Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Ann Rheum Dis. 2015 Jun;74(6):1178-82. doi: 10.1136/annrheumdis-2014-206404.
  • Qing Ye, Wen-xia Shao, Shi-qiang Shang, Ting Zhang, Jian Hu and Chun-chun Zhang
    A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease
    Arthritis Rheumatol. 2015 Jul;67(7):1943-50. doi: 10.1002/art.39112.
  • Michele Iudici, Xavier Puéchal, Christian Pagnoux, Pierre Quartier, Christian Agard, Achille Aouba, Matthias Büchler, Ramiro Cevallos, Pascal Cohen, Claire de Moreuil, Philippe Guilpain, Alain Le Quellec, Pascal Roblot, Jacques Serratrice, Claude Bachmeyer, Éric Daugas, Benjamin Terrier, Luc Mouthon, Loïc Guillevin and for the French Vasculitis Study Group
    Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry
    Arthritis Rheumatol. 2015 Jul;67(7):1959-65. doi: 10.1002/art.39122.
  • Singh S, Vignesh P, Burgner D.
    The epidemiology of Kawasaki disease: a global update.
    Arch Dis Child. 2015 Jun 25. pii: archdischild-2014-307536. doi: 10.1136/archdischild-2014-307536. [Epub ahead of print] Review.
  •  Burns JC, Franco A.
    The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.
    Expert Rev Clin Immunol. 2015 Jul;11(7):819-25. doi: 10.1586/1744666X.2015.1044980.
  • Maddox RA, Holman RC, Uehara R, Callinan LS, Guest JL, Schonberger LB, Nakamura Y, Yashiro M, Belay ED.
    Recurrent Kawasaki disease, United States and Japan.
    Pediatr Int. 2015 Jun 11. doi: 10.1111/ped.12733. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26096590
MAYO 2015
ABRIL 2015
  • Shulman ST, Rowley AH.
    Kawasaki disease: insights into pathogenesis and approaches to treatment.
    Nat Rev Rheumatol. 2015 Apr 28. doi: 10.1038/nrrheum.2015.54. [Epub ahead of print] Review.
  • Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, Lee MT, Wu JY, Lee CC.
    Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis

    BMJ Open. 2015 Apr 14;5(4):e006703. doi: 10.1136/bmjopen-2014-006703.
  • Merlin E, Mouy R, Pereira B, Mouthon L, Bourmaud A, Piette JC, Landman-Parker J, Chellun P, Layadi M, Thomas C, Guillevin L, Prieur AM, Quartier P.
    Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa

    Joint Bone Spine. 2015 Apr 14. pii: S1297-319X(15)00025-1. doi: 10.1016/j.jbspin.2015.01.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25887252  
  • Sacri AS, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, Flodrops H, Ulinski T, Allain-Launay E, Boyer O, Dunand O, Fischbach M, Hachulla E, Pietrement C, Le Pogamp P, Stephan JL, Belot A, Nivet H, Nobili F, Guillevin L, Quartier P, Deschênes G, Salomon R, Essig M, Harambat J.
    Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study

    Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i104-i112. doi: 10.1093/ndt/gfv011. Epub 2015 Feb 12.
MARZO 2015
  • Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA
    Predicting IVIG resistance in UK Kawasaki disease
    Arch Dis Child. 2015 Apr;100(4):366-8. doi: 10.1136/archdischild-2014-307397.
  • Kuo HC, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD.
    Identification of an Association Between Genomic Hypomethylation of FCGR2A and Susceptibility to Kawasaki Disease and Intravenous Immunoglobulin Resistance by DNA Methylation Array.
    Arthritis Rheumatol. 2015 Mar;67(3):828-36. doi: 10.1002/art.38976.
  • Ortiz-Sanjuan F, Blanco R, Hernandez JL, Gonzalez-Lopez MA, Loricera J, Lacalle-Calderon M, Pina T, Calvo-Rio V, Alvarez L, Gonzalez-Vela MC, Rueda-Gotor J, Gonzalez-Gay MA.
    Applicability of the 2006 European League Against Rheumatism (EULAR) criteria for the classification of Henoch-Schönlein purpura. An analysis based on 766 patients with cutaneous vasculitis.
    Clin Exp Rheumatol. 2015 Feb 9. [Epub ahead of print]
  • Avcu G, Sensoy G, Çeliksoy MH, Sogut A, Kefeli M, Karli A, Belet N.
    Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.
    Pediatr Int. 2015 Feb;57(1):155-7.
  • Gülhan B, Orhan D, Kale G, Besbas N, Özen S.
    Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura).
    Pediatr Nephrol. 2015 Feb 4.
  • Jorquera H, Borzutzky A, Hoyos-Bachiloglu R, García A.
    Association of Kawasaki disease with tropospheric winds in Central Chile: Is wind-borne desert dust a risk factor?
    Environ Int. 2015 Mar 2;78C:32-38.
  • Goo HW.
    Coronary Artery Imaging in Children.
    Korean J Radiol. 2015 Mar-Apr;16(2):239-250.
  • García Munitis P, Ves Losada J, Montali C.
    Acute abdomen at onset of incomplete and atypical Kawasaki disease: Case report.
    Arch Argent Pediatr. 2015 Apr 1;113(2):e88-93.
  • Aldemir-Kocabaş B, Kcal MM, Ramoğlu MG, Tutar E, Fitöz S, Çiftçi E, İnce E.
    Recurrent kawasaki disease in a child with retropharyngeal involvement: a case report and literature review.
    Medicine (Baltimore). 2014 Dec;93(29):e139.
  • Adjagba PM, Desjardins L, Fournier A, Spigelblatt L, Montigny M, Dahdah N.
    N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.
    Cardiol Young. 2014 Dec 29:1-8.
  • Pietraforte D, Gambardella L, Marchesi A, de Jacobis IT, Viora M, Del Principe D, Villani A, Malorni W, Straface E.
    Red blood cells as bioindicators of cardiovascular risk in Kawasaki disease: A case report.
    Int J Cardiol. 2014 Dec 13;181C:311-313.
  • Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
    Outcomes of Kawasaki Disease: A Single-Center Experience.
    Clin Pediatr (Phila). 2014 Dec 3. pii: 0009922814561594. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25475592
  • Başaran O, Cakar N, Uncu N, Celikel BA, Kara A, Cayci FS, Taktak A, Gür G.
    Plasma exchange therapy for severe gastrointestinal involvement of Henoch Schönlein purpura in children.
    Clin Exp Rheumatol. 2014 Dec 1. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25436762
  • Eleftheriou D, Batu ED, Ozen S, Brogan PA.
    Vasculitis in children.
    Nephrol Dial Transplant. 2014 Dec 30. pii: gfu393. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25550447
  • Borroni G1, Grassi S, Carugno A.
    Vasculitides with cutaneous expression in children: clinic-pathologic correlations.
    G Ital Dermatol Venereol. 2014 Dec 17. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25516220
  • Bas A, Samanci C, Numan F.
    Percutaneous transcatheter embolization of gastrointestinal bleeding in a child with polyarteritis nodosa.
    Pol J Radiol. 2014 Dec 11;79:465-6.
  • López-Mejías R, Genre F, Pérez BS, Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Remuzgo-Martínez S, Mijares V, Pina T, Calvo-Río V, Márquez A, Sala-Icardo L, Miranda-Filloy JA, Conde-Jaldón M, Ortiz-Fernández L, Rubio E, León Luque M, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, González-Vela MC, Ocejo-Vinyals JG, González Escribano F, Martín J, Blanco R, González-Gay MA
    HLA-DRB1 association with Henoch-Schonlein purpura.
    Arthritis Rheumatol. 2014 Dec 2. doi: 10.1002/art.38979. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25470797
  • Kuo HC, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD.
    DNA methylation array identifies genomic hypomethylation of FCGR2A in the susceptibility of Kawasaki disease and intravenous immunoglobulin resistance.
    Arthritis Rheumatol. 2014 Dec 2. doi: 10.1002/art.38976. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25470559
  • Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
    Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Rheumatol Int. 2014 Nov 28. [Epub ahead of print]
  • Ni FF, Li CR, Li Q, Xia Y, Wang GB, Yang J.
    Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.
    Clin Exp Immunol. 2014 Nov;178(2):384-93.
  • Li X, Liang S, Zheng C, Zeng C, Zhang H, Hu W, Liu Z.
    Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.
    Pediatr Nephrol. 2014 Dec;29(12):2365-71.
  • Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, Takeuchi M.
    Neonatal Kawasaki disease: case report and data from nationwide survey in Japan.
    Eur J Pediatr. 2014 Nov;173(11):1533-6.
  • Lin YJ, Lan YC, Lai CH, Lin TH, Huang SM, Liao CC, Lin CW, Hung CH, Tien N, Liu X, Chien WK, Chen JH, Tsai FJ.
    Association of promoter genetic variants in interleukin-10 and kawasaki disease with coronary artery aneurysms.
    J Clin Lab Anal. 2014 Nov;28(6):461-4.
  • Teng X, Wang Y, Lin N, Sun M, Wu J.
    Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.
    Clin Rheumatol. 2014 Oct 3. [Epub ahead of print]
  • Johnson EF, Lehman JS, Wetter DA, Lohse CM, Tollefson MM.
    Henoch-Schonlein purpura and systemic disease in children: Retrospective study of clinical findings, histopathology, and direct immunofluorescence in 34 pediatric patients.
    Br J Dermatol. 2014 Oct 11. doi: 10.1111/bjd.13472. [Epub ahead of print]
  • Salah S, Rizk S, Lotfy HM, El Houchi S, Marzouk H, Farag Y.
    MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura.
    Pediatr Rheumatol Online J. 2014 Sep 9;12:41. doi: 10.1186/1546-0096-12-41. eCollection 2014.
  • Han BK, Lesser A, Rosenthal K, Dummer K, Grant K, Newell M.
    Coronary Computed Tomographic Angiographic Findings in Patients With Kawasaki Disease.
    Am J Cardiol. 2014 Sep 16. pii: S0002-9149(14)01776-7. doi: 10.1016/j.
  • Özlem Bağ, Utku Karaarslan, Çiğdem Ecevit, Gül İrem Kanberoğlu, Aysel Öztürk
    The Value of Platelet Indices in Henoch- Schonlein Purpura
    Ann Paediatr Rheum. 2014; 3(3): 126- 131
  • Zhang PP1, Li YT, Li XF, Pan L, Chen ZG.
    Clinical research on serum lipid changes in children with Kawasaki disease and its relationship with coronary artery lesions.
    Clin Exp Rheumatol. 2014 Sep 19. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25237009
  • Ruby Haviv, Maya Capua, Jacob Amir and Liora Harel
    Cutaneous polyarteritis nodosa successfully treated with topical diflucortolone valerate – a case report & review of the literatura.
    Pediatric Rheumatology 2014, 12:46  doi:10.1186/1546-0096-12-46
  • JCS Joint Working Group
    Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2013).
    Circ J. 2014 Sep 25;78(10):2521-2562. Epub 2014 Sep 22.
  • Moffett BS, Syblik D, Denfield S, Altman C, Tejtel-Sexson K.
    Epidemiology of Immunoglobulin Resistant Kawasaki Disease: Results from a Large, National Database.
    Pediatr Cardiol. 2014 Sep 2. [Epub ahead of print].
  • Lally L, Lebovics RS, Huang WT, Spiera RF.
    Effectiveness of Rituximab for the otolaryngologic manifestations of Granulomatosis With Polyangiitis (Wegener’s).
    Arthritis Care Res (Hoboken) 2014 Sep;66(9):1403-1409.
  • Comarmond C, Cacoub P.
    Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment.
    Autoimmun Rev. 2014 Aug 20. pii: S1568-9972(14)00161-X. doi: 10.1016/j.autrev.2014.08.017. [Epub ahead of print]
  • Guillevin L
    Treatment of severe and/or refractory ANCA-associated vasculitis.
    Curr Rheumatol Rep. 2014 Aug;16(8):430. doi: 10.1007/s11926-014-0430-y.
  • Smith KA1, Yunker WK2.
    Kawasaki disease is associated with sensorineural hearing loss: A systematic review.
    Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1216-1220.
  • Sun L1, Wang H2, Jiang X1, Mo Y2, Yue Z2, Huang L2, Liu T2.
    Clinical and pathological features of microscopic polyangiitis in 20 children.
    J Rheumatol. 2014 Aug;41(8):1712-9.
  • Moore A, Harnden A, Mayon-White R.
    Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.
    Br J Gen Pract. 2014 Aug;64(625):e477-83.
JULIO 2014
  • Davin JC, Coppo R.
    Henoch-Schönlein purpura nephritis in children.
    Nat Rev Nephrol. 2014 Jul 29. doi: 10.1038/nrneph.2014.126. [Epub ahead of print].
  • Xing Y1, Wang H, Liu X, Yu X, Chen R, Wang C, Yu X, Sun L.
    Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease.
    Mol Biol Rep. 2014 Jul 3.
  • Zhao JM1, Wang XH.
    Clinical significance of anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies in children with Kawasaki disease.
    Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jul;16(7):740-4.
  • Li X1, Liang S, Zheng C, Zeng C, Zhang H, Hu W, Liu Z.
    Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.
    Pediatr Nephrol. 2014 Jul 16.
  • Ni FF1, Li CR, Li Q, Xia Y, Wang GB, Yang J.
    Regulatory T-cell microRNA expression changes in children with acute Kawasaki disease.
    Clin Exp Immunol. 2014 Jul 16.
  • Shafferman A1, Birmingham JD2, Cron RQ3.
    High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report.
    Pediatr Rheumatol Online J. 2014 Jul 11;12:26.
  • Puhakka L1, Saat R2, Klockars T3, Kajosaari L3, Salo E4, Nieminen T4.
    Retropharyngeal involvement in Kawasaki disease-A report of four patients with retropharyngeal edema verified by magnetic resonance imaging.
    Int J Pediatr Otorhinolaryngol. 2014 Jul 12.
  • Fujimaru T1, Ito S2, Masuda H3, Oana S3, Kamei K1, Ishiguro A3, Kato H4, Abe J5.
    Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Cytokine. 2014 Jul 28. pii: S1043-4666(14)00213-0.
JUNIO 2014
  • Dimitriades VR, Brown AG,Gedalia A.
    Kawasaki disease: pathophysiology, clinical manifestations, and management
    Curr Rheumatol Rep. 2014 Jun;16(6):423.
  • Szugye HS1, Zeft AS2, Spalding SJ3.
    Takayasu Arteritis in the pediatric population: a contemporary United States-Based Single Center Cohort.
    Pediatr Rheumatol Online J. 2014 Jun 4;12:21. doi: 10.1186/1546-0096-12-21. eCollection 2014.
  • Smith KA1, Yunker WK2.
    Kawasaki disease is associated with sensorineural hearing loss: A systematic review.
    Int J Pediatr Otorhinolaryngol. 2014 Jun 2. pii: S0165-5876(14)00294-8. doi: 10.1016/j.ijporl.2014.05.026. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24951399
  • Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, Takeuchi M.
    Neonatal Kawasaki disease: case report and data from nationwide survey in Japan.
    Eur J Pediatr. 2014 Jun 3. [Epub ahead of print]
  • Rodó X, Curcoll R, Robinson M, Ballester J, Burns JC, Cayan DR, Lipkin WI, Williams BL, Couto-Rodriguez M, Nakamura Y, Uehara R, Tanimoto H, Morguí JA.
    Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.
    Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7952-7957.
  • Dimitriades VR1, Brown AG, Gedalia A.
    Kawasaki disease: pathophysiology, clinical manifestations, and management.
    Curr Rheumatol Rep. 2014 Jun;16(6):423. doi: 10.1007/s11926-014-0423-x.
  • Stagi S1, Bertini F2, Rigante D3, Falcini F2.
    Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.
    Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):964-8. doi: 10.1016/j.ijporl.2014.03.026. Epub 2014 Apr 1.
MAYO 2014
  • Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis).
    Pediatr Rheumatol Online J. 2014 May 26;12:18. doi: 10.1186/1546-0096-12-18. eCollection 2014.
  • Tremoulet AH, Jain S, Jaggi P, et al.
    Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Lancet. 2014 May 17;383 (9930):1731-8.
  •  Scuccimarri R1, Yeung RS2.
    Kawasaki disease: High index of suspicion needed in a febrile child.
    Paediatr Child Health. 2014 May;19(5):239-40.
  • D'Alessandro M1, Buoncompagni A, Minoia F, Coccia MC, Martini A, Picco P.
    Cytomegalovirus-related necrotising vasculitis mimicking Henoch-Schönlein syndrome.
    Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):73-5. Epub 2014 May 16.
  • Fujino M1, Hata T, Kuriki M, Horio K, Uchida H, Eryu Y, Boda H, Miyata M, Yoshikawa T.
    Inflammation Aggravates Heterogeneity of Ventricular Repolarization in Children With Kawasaki Disease.
    Pediatr Cardiol. 2014 May 14. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24823886
ABRIL 2014
MARZO 2014
  • Cellucci T1, Tyrrell PN, Twilt M, Sheikh S, Benseler SM.
    Distinct phenotype clusters in childhood inflammatory brain diseases: implications for diagnostic evaluation.
    Arthritis Rheumatol. 2014 Mar;66(3):750-6. doi: 10.1002/art.38274.
  • Zhou Q1, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A,Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, MullikinJC,Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA,Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I.
    Early-onset stroke and vasculopathy associated with mutations in ADA2.
    N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.
  • NavonElkan P1, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E,Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, ShohatM,Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E.
    Mutant adenosine deaminase 2 in a polyarteritisnodosa vasculopathy.
    N Engl J Med. 2014 Mar 6;370(10):921-31. doi: 10.1056/NEJMoa1307362. Epub 2014 Feb 19.
  • Pietraforte D, Gambardella L, Marchesi A, Tarissi de Jacobis I, Villani A, Del Principe D, Malorni W, Straface E.
    Platelets in Kawasaki patients: Two different populations with different mitochondrial functions.
    Int J Cardiol. 2014 Mar 15;172(2):526-8. doi: 10.1016/j.ijcard.2014.01.022. Epub 2014 Jan 22.
  • Kwak JH, Song J, Kang IS, Huh J, Lee HJ.
    Changes in coronary perfusion after occlusion of coronary arteries in kawasaki disease.
    Yonsei Med J. 2014 Mar 1;55(2):353-9. doi: 10.3349/ymj.2014.55.2.353.
  • Kawasaki T, Naoe S.
    History of Kawasaki disease.
    Clin Exp Nephrol. 2014 Mar 6. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24595558
  • Talukder MK, Islam MI, Rahman SA.
    Clinical and laboratory profile of childhood polyarteritis nodosa in a Bangladeshi tertiary hospital.
    Int J Rheum Dis. 2014 Mar 6. doi: 10.1111/1756-185X.12319. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24597834
  • van Oers HA, Tacke CE, Haverman L, Kuipers IM, Maurice-Stam H, Kuijpers TW, Grootenhuis MA.
    Health Related Quality of Life and Perceptions of Child Vulnerability among parents of children with a history of Kawasaki Disease.
    Acta Paediatr. 2014 Mar 3. doi: 10.1111/apa.12619. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24588557
  • Durmaz B, Aykut A, Hursitoglu G, Bak M, Serdaroglu E, Onay H, Ozkinay F.
    Association of mannose binding lectin codon 54 polymorphism with predisposition to Henoch-Schönlein purpura in childhood.
    Int J Rheum Dis. 2014 Feb 28. doi: 10.1111/1756-185X.12321. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24576294
  • Rheumatol Int. 2014 Feb 23. [Epub ahead of print] Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura.
    Masarweh K, Horovitz Y, Avital A, Spiegel R.
  • Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB.
    Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura.
    J Korean Med Sci. 2014 Feb;29(2):198-203. doi: 10.3346/jkms.2014.29.2.198. Epub 2014 Jan 28.
  • López-Mejías R, Sevilla Pérez B, Genre F, Castañeda S, Ortego-Centeno N, Miranda-Filloy JA, Llorca J, Martín J, Blanco R, González-Gay MA.
    Lack of association between IL6 gene and Henoch-Schönlein purpura.
    Clin Exp Rheumatol. 2014 Feb 11. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24528956
  • Luca CM, Laicini EA, Fossali EF.
    Eosinophil cationic protein in Henoch-Schönlein purpura.
    World J Pediatr. 2014 Feb;10(1):90-1. doi: 10.1007/s12519-014-0462-4.
  • Suthar R, Singh S, Bhalla AK, Attri SV.
    Pattern of subcutaneous fat during follow-up of a cohort of North Indian children with Kawasaki disease: a preliminary study.
    Int J Rheum Dis. 2014 Feb 11. doi: 10.1111/1756-185X.12296. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24517191
  • Tamaki W, Tsuda E, Takehiro I, Tanaka N, Fujieda M.
    Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients afterKawasaki disease: a right parasternal approach.
    Heart Vessels. 2014 Feb 9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24510254
  • Hwang B.
    Epidemiology of Kawasaki Disease.
    Pediatr Neonatol. 2014 Feb 6. pii: S1875-9572(13)00222-2. doi: 10.1016/j.pedneo.2013.10.008. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24508358
  • Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, Cheng AL, Lee WL, Hu JJ, Yeh SJ, Chang CC, Chiang BL, Wu MH, Huang LM.
    Viral infections associated with Kawasaki disease.
    J Formos Med Assoc. 2014 Feb 1. pii: S0929-6646(14)00003-5. doi: 10.1016/j.jfma.2013.12.008. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24495555
  • Sci Rep. 2014 Feb 28;4:4247. doi: 10.1038/srep04247.
    8p22-23-rs2254546 as a Susceptibility Locus for Kawasaki Disease: a Case-control Study and a Meta-analysis.
    Wang W, Lou J, Lu XZ, Qi YQ, Shen N, Zhong R, Wang YJ, Zou L, Zhang Q, Duan JY, Ke JT, Miao XP, Gong FQ.
  • Levin M, Burgner D.
    Treatment of Kawasaki disease with anti-TNF antibodies.
    Lancet. 2014 Feb 21. pii: S0140-6736(14)60131-8. doi: 10.1016/S0140-6736(14)60131-8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24572998
  • S M, Singh S, Suri D, Gupta A, Gupta A.
    Acute Anterior Uveitis as the Presenting Feature of Kawasaki Disease.
    Indian J Pediatr. 2014 Feb 25. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24562721
  • Sonoda K, Mori M, Hokosaki T, Yokota S.
    Infliximab Plus Plasma Exchange Rescue Therapy in Kawasaki Disease.
    J Pediatr. 2014 Feb 19. pii: S0022-3476(14)00026-2. doi: 10.1016/j.jpeds.2014.01.020. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24560183
  • Yi DY, Kim JY, Choi EY, Choi JY, Yang HR.
    Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children.
    BMC Pediatr. 2014 Feb 18;14(1):51. doi: 10.1186/1471-2431-14-51.
  • Durmaz B, Aykut A, Hursitoglu G, Bak M, Serdaroglu E, Onay H, Ozkinay F.
    Association of mannose binding lectin codon 54 polymorphism with predisposition to Henoch-Schönlein purpura in childhood.
    Int J Rheum Dis. 2014 Feb 28. doi: 10.1111/1756-185X.12321. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24576294
  • Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Lancet. 2014 Feb 21. pii: S0140-6736(13)62298-9. doi: 10.1016/S0140-6736(13)62298-9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24572997
  • Duan C, Du ZD, Wang Y, Jia LQ.
    Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
    World J Pediatr. 2014 Mar 6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24599612
  • Awaya A, Nishimura C.
    A Combination of Cross Correlation and Trend Analyses Reveals that Kawasaki Disease is a Pollen-Induced Delayed-Type Hyper-Sensitivity Disease.
    Int J Environ Res Public Health. 2014 Mar 4;11(3):2628-41. doi: 10.3390/ijerph110302628.
  • Holve TJ, Patel A, Chau Q, Marks AR, Meadows A, Zaroff JG.
    Long-term Cardiovascular Outcomes in Survivors of Kawasaki Disease.
    Pediatrics. 2014 Feb;133(2):e305-11. doi: 10.1542/peds.2013-1638. Epub 2014 Jan 20.
ENERO 2014
  • Tacke CE, Breunis WB, Pereira RR, Breur JM, Kuipers IM, Kuijpers TW.
    Five Years of Kawasaki Disease in the Netherlands: A National Surveillance Study.
    Pediatr Infect Dis J. 2014 Jan 23. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24463809
  • Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA.
    Management of Kawasaki disease.
    Arch Dis Child. 2014 Jan;99(1):74-83. doi: 10.1136/archdischild-2012-302841.
  • Trnka P.
    Henoch-Schönlein purpura in children.
    J Paediatr Child Health. 2013 Oct 18.
  • Mondal R, Sarkar S, Pal P, Nandi M, Hazra A, Sabui TK.
    Childhood Polyarteritis Nodosa: A Prospective Multicentre Study from Eastern India.
    Indian J Pediatr. 2013 Oct 10.
  • Bayers S, Shulman ST, Paller AS.
    Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
    J Am Acad Dermatol. 2013 Oct;69(4):501.
  • Bayers S, Shulman ST, Paller AS.
    Kawasaki disease: part II. Complications and treatment.
    J Am Acad Dermatol. 2013 Oct;69(4):513.
  • Rhim JW, Youn YS, Han JW, Lee SJ, Oh JH, Lee KY.
    Changes in Kawasaki Disease during Two Decades at a Single Institution in Daejeon, Korea.
    Pediatr Infect Dis J. 2013 Oct 18.
  • Noto N, Kamiyama H, Karasawa K, Ayusawa M, Sumitomo N, Okada T, Takahashi S.
    Long-term prognostic impact of dobutamine stress echocardiography in patients with Kawasaki disease and coronary artery lesions: A 15-year follow-up study.
    J Am Coll Cardiol. 2013 Oct 1. pii: S0735-1097(13)05454-5.
  • Lue HC, Chen LR, Lin MT, Chang LY, Wang JK, Lee CY, Wu MH.
    Epidemiological Features of Kawasaki Disease in Taiwan, 1976-2007: Results of Five Nationwide Questionnaire Hospital Surveys.
    Pediatr Neonatol. 2013 Oct 10.
  • Hoyer PF.
    Prevention of renal disease inHenoch-Schonlein purpura: clear evidence against steroids.
    Arch Dis Child. 2013 Oct;98(10):750-1.
  • Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J.
    Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP).
    Arch Dis Child. 2013 Oct;98(10):756-63
  • Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Choi JY, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczyk E, Lee EY, Song YW, Ohno S, Lee EB.
    Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease.
    Ann Rheum Dis. 2013 Sep 1;72(9):1510-6. doi: 10.1136/annrheumdis-2011-200288.
  • Dolezalova P, Price-Kuehne FE, Ozen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O'Neil KM, Wallace CA, Wilkinson N, Eleftheriou D, Demirkaya E, Böhm M, Krol P, Luqmani RA, Brogan PA.
    Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
    Ann Rheum Dis. 2013 Oct 1;72(10):1628-33. doi: 10.1136/annrheumdis-2012-202111.
  • Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, Klein NJ, Brogan PA.
    Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years.
    Arthritis Rheum. 2013 Sep;65(9):2476-85. doi: 10.1002/art.38024.
  • Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
    Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease.
    J Pediatr. 2013 Aug;163(2):521-526.e1. doi: 10.1016/j.jpeds.2013.01.022. Epub 2013 Feb 26.
JUNIO 2013
  • Gendelman S, Zeft A, Spalding SJ.
    Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort.
    J Rheumatol. 2013 Jun;40(6):929-35. doi: 10.3899/jrheum.120808. Epub 2013 May 1.
MAYO 2013
MARZO 2013
  • Ben Ameur S, Niaudet P, Baudouin V, Bourgeois ML, Houdouin V, Delacourt C, Hadchouel A.
    Lung manifestations in MPO-ANCA associated vasculitides in children.
    Pediatr Pulmonol. 2013 Mar 26. doi: 10.1002/ppul.22793. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23532899
  • Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.
  • Lega JC, Bozio A, Cimaz R, Veyrier M, Floret D, Ducreux C, Reix P, Di Filippo S.
    Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease.
    Arch Dis Child. 2013 Feb;98(2):97-102. doi: 10.1136/archdischild-2011-301256. Epub 2012 Dec 12.
ENERO 2013
  • Ling XB, Kanegaye JT, Ji J, Peng S, Sato Y, Tremoulet A, Burns JC,Cohen HJ.
    Point-of-care differentiation of Kawasaki disease from other febrile illnesses.
    J Pediatr. 2013 Jan;162:183-8.e3. doi: 10.1016/j.jpeds.2012.06.012. Epub 2012 Jul 20.
  • Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N,Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA.
    2012 revised international chapel hill consensus conference nomenclature of vasculitides.
    Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.
  • Splendiani A, Catalucci A, Limbucci N, Turner M, Krings T, Gallucci M.
    Pediatric Inflammatory Diseases. Part III: Small Vessels Vasculitis.
    Neuroradiol J. 2012 Dec 20;25(6):715-24.